2024/02/02 更新

写真a

モリタ リンペイ
森田 林平
Morita Rimpei
所属
大学院医学研究科 微生物学・免疫学分野 大学院教授
医学部 微生物学・免疫学 大学院教授
職名
大学院教授
外部リンク

学位

  • 博士(医学) ( 2003年7月   京都大学 )

研究キーワード

  • マクロファージ

  • 自然免疫

  • サイトカイン

  • 炎症

研究分野

  • ライフサイエンス / 免疫学

  • ライフサイエンス / 実験病理学  / 炎症

学歴

  • 京都大学   大学院医学研究科   血液・腫瘍内科学

    1998年4月 - 2002年3月

      詳細を見る

    国名: 日本国

    researchmap

  • 奈良県立医科大学   医学部

    1989年4月 - 1995年3月

      詳細を見る

  • 東北大学   理学部   化学科

    1988年4月 - 1989年3月

      詳細を見る

経歴

  • 日本医科大学   微生物学・免疫学教室   教授

    2019年7月 - 現在

      詳細を見る

    国名:日本国

    researchmap

  • 国際医療福祉大学 医学部   免疫学   教授

    2017年4月 - 2019年6月

      詳細を見る

    国名:日本国

    researchmap

  • 慶應義塾大学医学部   微生物学・免疫学   准教授

    2015年1月 - 2017年3月

      詳細を見る

    国名:日本国

    researchmap

  • 慶應義塾大学医学部   微生物学・免疫学   専任講師

    2010年4月 - 2014年12月

      詳細を見る

    国名:日本国

    researchmap

  • 慶應義塾大学医学部   微生物学・免疫学   助教

    2009年8月 - 2010年3月

      詳細を見る

    国名:日本国

    researchmap

  • Yale大学   Flavell 研究室   ポスドク

    2008年6月 - 2009年8月

      詳細を見る

    国名:アメリカ合衆国

    researchmap

  • ベイラー免疫学研究所   Banchereau 研究室   ポスドク

    2005年1月 - 2008年5月

      詳細を見る

    国名:アメリカ合衆国

    researchmap

  • 京都大学大学院 医学研究科   先端領域融合医学研究機構   助手(特任)

    2003年4月 - 2005年1月

      詳細を見る

▼全件表示

委員歴

  • 日本免疫学会   評議員  

    2019年1月 - 現在   

      詳細を見る

    団体区分:学協会

    researchmap

論文

  • Inflammation in preterm birth: Novel mechanism of preterm birth associated with innate and acquired immunity. 国際誌

    Yasuyuki Negishi, Yoshio Shima, Masahiko Kato, Tomoko Ichikawa, Hajime Ino, Yumi Horii, Shunji Suzuki, Rimpei Morita

    Journal of reproductive immunology   154   103748 - 103748   2022年12月

     詳細を見る

    担当区分:最終著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Preterm birth (PB) is the most-frequent complication occurring during pregnancy, with a significant impact on neonatal morbidity and mortality. Chorioamnionitis (CAM), the neutrophil infiltration into chorioamniotic membranes, is a major cause of PB. However, several cases of PB have also been reported without apparent pathogenic infection or CAM. Such cases are now attributed to "sterile inflammation." The concept of sterile inflammation has already attracted attention in various diseases, like cardiovascular diseases, diabetes, and autoimmune diseases; recently been discussed for obstetric complications such as miscarriage, PB, gestational hypertension, and gestational diabetes. Sterile inflammation is induced by alarmins, such as high-mobility group box 1 (HMGB1), interleukins (IL-33 and IL-1α), and S100 proteins, that are released by cellular damage without apparent pathogenic infection. These antigens are recognized by pattern-recognition receptors, expressed mainly on antigen-presenting cells of decidua, placenta, amnion, and myometrium, which consequently trigger inflammation. In reproduction, these alarmins are associated with the development of various pregnancy complications, including PB. In this review, we have summarized the development of PB related to acute CAM, chronic CAM, and sterile inflammation as well as proposed a new mechanism for PB that involves innate immunity, acquired immunity, and sterile inflammation.

    DOI: 10.1016/j.jri.2022.103748

    PubMed

    researchmap

  • Generation and application of human induced-stem cell memory T cells for adoptive immunotherapy. 査読 国際誌

    Kondo T, Imura Y, Chikuma S, Hibino S, Omata-Mise S, Ando M, Akanuma T, Iizuka M, Sakai R, Morita R, Yoshimura A

    Cancer science   109 ( 7 )   2130 - 2140   2018年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1111/cas.13648

    PubMed

    researchmap

  • MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1 査読

    Takashi Shichita, Minako Ito, Rimpei Morita, Kyoko Komai, Yoshiko Noguchi, Hiroaki Ooboshi, Ryusuke Koshida, Satoru Takahashi, Tatsuhiko Kodama, Akihiko Yoshimura

    Nature Medicine   23 ( 6 )   723 - 732   2017年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:Nature Publishing Group  

    Damage-associated molecular patterns (DAMPs) trigger sterile inflammation after tissue injury, but the mechanisms underlying the resolution of inflammation remain unclear. In this study, we demonstrate that common DAMPs, such as high-mobility-group box 1 (HMGB1), peroxiredoxins (PRXs), and S100A8 and S100A9, were internalized through the class A scavenger receptors MSR1 and MARCO in vitro. In ischemic murine brain, DAMP internalization was largely mediated by MSR1. An elevation of MSR1 levels in infiltrating myeloid cells observed 3 d after experimental stroke was dependent on the transcription factor Mafb. Combined deficiency for Msr1 and Marco, or for Mafb alone, in infiltrating myeloid cells caused impaired clearance of DAMPs, more severe inflammation, and exacerbated neuronal injury in a murine model of ischemic stroke. The retinoic acid receptor (RAR) agonist Am80 increased the expression of Mafb, thereby enhancing MSR1 expression. Am80 exhibited therapeutic efficacy when administered, even at 24 h after the onset of experimental stroke. Our findings uncover cellular mechanisms contributing to DAMP clearance in resolution of the sterile inflammation triggered by tissue injury.

    DOI: 10.1038/nm.4312

    Scopus

    PubMed

    researchmap

  • Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy 査読

    Taisuke Kondo, Rimpei Morita, Yuumi Okuzono, Hiroko Nakatsukasa, Takashi Sekiya, Shunsuke Chikuma, Takashi Shichita, Mitsuhiro Kanamori, Masato Kubo, Keiko Koga, Takahiro Miyazaki, Yoshiaki Kassai, Akihiko Yoshimura

    NATURE COMMUNICATIONS   8   15338   2017年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Adoptive T-cell immunotherapy is a promising approach to cancer therapy. Stem cell memory T (T-SCM) cells have been proposed as a class of long-lived and highly proliferative memory T cells. CD8(+) TSCM cells can be generated in vitro from naive CD8(+) T cells via Wnt signalling; however, methods do not yet exist for inducing T-SCM cells from activated or memory T cells. Here, we show a strategy for generating T-SCM-like cells in vitro (iT(SCM) cells) from activated CD4(+) and CD8(+) T cells in mice and humans by coculturing with stromal cells that express a Notch ligand. iT(SCM) cells lose PD-1 and CTLA-4 expression, and produce a large number of tumour-specific effector cells after restimulation. This method could therefore be used to generate antigen-specific effector T cells for adoptive immunotherapy.

    DOI: 10.1038/ncomms15338

    Web of Science

    PubMed

    researchmap

  • Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease. 査読

    Akiyama M, Yasuoka H, Yamaoka K, Suzuki K, Kaneko Y, Kondo H, Kassai Y, Koga K, Miyazaki T, Morita R, Yoshimura A, Takeuchi T

    Arthritis research & therapy   18   167   2016年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1186/s13075-016-1064-4

    Web of Science

    PubMed

    researchmap

  • Smad2 and Smad3 Inversely Regulate TGF-β Autoinduction in Clostridium butyricum-Activated Dendritic Cells. 査読

    Kashiwagi I, Morita R, Schichita T, Komai K, Saeki K, Matsumoto M, Takeda K, Nomura M, Hayashi A, Kanai T, Yoshimura A

    Immunity   43 ( 1 )   65 - 79   2015年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.immuni.2015.06.010

    Web of Science

    PubMed

    researchmap

  • Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury 査読

    Minako Ito, Takashi Shichita, Masahiro Okada, Ritsuko Komine, Yoshiko Noguchi, Akihiko Yoshimura, Rimpei Morita

    NATURE COMMUNICATIONS   6   7360   2015年6月

     詳細を見る

    担当区分:責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Inflammasome activation has been implicated in various inflammatory diseases including post-ischaemic inflammation after stroke. Inflammasomes mediate activation of caspase-1, which subsequently induces secretion of pro-inflammatory cytokines such as IL-1 beta and IL-18, as well as a form of cell death called pyroptosis. In this study, we report that Bruton's tyrosine kinase (BTK) is an essential component of the NLRP3 inflammasome, in which BTK physically interacts with ASC and NLRP3. Inhibition of BTK by pharmacological or genetic means severely impairs activation of the NLRP3 inflammasome. The FDA-approved BTK inhibitor ibrutinib (PCI-32765) efficiently suppresses infarct volume growth and neurological damage in a brain ischaemia/reperfusion model in mice. Ibrutinib inhibits maturation of IL-1 beta by suppressing caspase-1 activation in infiltrating macrophages and neutrophils in the infarcted area of ischaemic brain. Our study indicates that BTK is essential for NLRP3 inflammasome activation and could be a potent therapeutic target in ischaemic stroke.

    DOI: 10.1038/ncomms8360

    Web of Science

    PubMed

    researchmap

  • AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites 査読

    Lark Kyun Kim, Rimpei Morita, Yasushi Kobayashi, Stephanie C. Eisenbarth, Chun Geun Lee, Jack Elias, Elizabeth E. Eynon, Richard A. Flavell

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   112 ( 22 )   E2891 - E2899   2015年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATL ACAD SCIENCES  

    Chitinases are enzymes that cleave chitin, a component of the exoskeleton of many organisms including the house dust mite (HDM). Here we show that knockin mice expressing an enzymatically inactive acidic mammalian chitinase (AMCase), the dominant true chitinase in mouse lung, showed enhanced type 2 immune responses to inhaled HDM. We found that uncleaved chitin promoted the release of IL-33, whereas cleaved chitin could be phagocytosed and could induce the activation of caspase-1 and subsequent activation of caspase-7; this results in the resolution of type 2 immune responses, probably by promoting the inactivation of IL-33. These data suggest that AMCase is a crucial regulator of type 2 immune responses to inhaled chitin-containing aeroallergens.

    DOI: 10.1073/pnas.1507393112

    Web of Science

    PubMed

    researchmap

  • ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells 査読

    Rimpei Morita, Mayu Suzuki, Hidenori Kasahara, Nana Shimizu, Takashi Shichita, Takashi Sekiya, Akihiro Kimura, Ken-ichiro Sasaki, Hideo Yasukawa, Akihiko Yoshimura

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA   112 ( 1 )   160 - 165   2015年1月

     詳細を見る

    担当区分:筆頭著者, 責任著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATL ACAD SCIENCES  

    Transplantation of endothelial cells (ECs) is a promising therapeutic approach for ischemic disorders. In addition, the generation of ECs has become increasingly important for providing vascular plexus to regenerated organs, such as the liver. Although many attempts have been made to generate ECs from pluripotent stem cells and nonvascular cells, the minimum number of transcription factors that specialize in directly inducing vascular ECs remains undefined. Here, by screening 18 transcription factors that are important for both endothelial and hematopoietic development, we demonstrate that ets variant 2 (ETV2) alone directly converts primary human adult skin fibroblasts into functional vascular endothelial cells (ETVECs). In coordination with endogenous FOXC2 in fibroblasts, transduced ETV2 elicits expression of multiple key endothelial development factors, including FLI1, ERG, and TAL1, and induces expression of endothelial functional molecules, including EGFL7 and von Willebrand factor. Consequently, ETVECs exhibits EC characteristics in vitro and forms mature functional vasculature in Matrigel plugs transplanted in NOD SCID mice. Furthermore, ETVECs significantly improve blood flow recovery in a hind limb ischemic model using BALB/c-nu mice. Our study indicates that the creation of ETVECs provides further understanding of human EC development induced by ETV2.

    DOI: 10.1073/pnas.1413234112

    Web of Science

    PubMed

    researchmap

  • Human Blood CXCR5(+)CD4(+) T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody Secretion 査読

    Rimpei Morita, Nathalie Schmitt, Salah-Eddine Bentebibel, Rajaram Ranganathan, Laure Bourdery, Gerard Zurawski, Emile Foucat, Melissa Dullaers, SangKon Oh, Natalie Sabzghabaei, Elizabeth M. Lavecchio, Marilynn Punaro, Virginia Pascual, Jacques Banchereau, Hideki Ueno

    IMMUNITY   34 ( 1 )   108 - 121   2011年1月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CELL PRESS  

    Although a fraction of human blood memory CD4(+) T cells expresses chemokine (C-X-C motif) receptor 5 (CXCR5), their relationship to T follicular helper (Tfh) cells is not well established. Here we show that human blood CXCR5(+)CD4(+) T cells share functional properties with Tfh cells and appear to represent their circulating memory compartment. Blood CXCR5(+)CD4(+) T cells comprised three subsets: T helper 1 (Th1), Th2, and Th17 cells. Th2 and Th17 cells within CXCR5(+), but not within CXCR5(-), compartment efficiently induced naive B cells to produce immunoglobulins via interleukin-21 (IL-21). In contrast, Th1 cells from both CXCR5(+) and CXCR5(-) compartments lacked the capacity to help B cells. Patients with juvenile dermatomyositis, a systemic autoimmune disease, displayed a profound skewing of blood CXCR5(+) Th cell subsets toward Th2 and Th17 cells. Importantly, the skewing of subsets correlated with disease activity and frequency of blood plasmablasts. Collectively, our study suggests that an altered balance of Tfh cell subsets contributes to human autoimmunity.

    DOI: 10.1016/j.immuni.2010.12.012

    Web of Science

    PubMed

    researchmap

  • Human Dendritic Cells Induce the Differentiation of Interleukin-21-Producing T Follicular Helper-like Cells through Interleukin-12 査読

    Nathalie Schmitt, Rimpei Morita, Laure Bourdery, Salah Eddine Bentebibel, Sandra M. Zurawski, Jacques Banchereau, Hideki Ueno

    IMMUNITY   31 ( 1 )   158 - 169   2009年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CELL PRESS  

    T follicular helper (Tfh) cells help development of antibody responses via interleukin-21 (IL-21). Here we show that activated human dendritic cells (DCs) induced naive CD4(+) T cells to become IL-21-producing Tfh-like cells through IL-12. CD4(+) T cells primed with IL-12 induced B cells to produce immunoglobulins in a fashion dependent on IL-21 and inducible costimulator (ICOS), thus sharing fundamental characteristics with Tfh cells. The induction of Tfh-like cells by activated DCs was inhibited by neutralizing IL-12. IL-12 induced two different IL-21-producers: IL-21(+)IFN-gamma(+)T-bet(+) Th1 cells and IL-21(+)IFN-gamma(+)T-bet(-) non-Th1 cells, in a manner dependent on signal transducer and activator of transcription 4 (STAT4). IL-12 also regulated IL-21 secretion by memory CD4(+) T cells. Thus, IL-12 produced by activated DCs regulates antibody responses via developing IL-21-producing Tflh-like cells and inducing IL-21 secretion from memory CD4(+) T cells. These data suggest that the developmental pathway of Tfh cells differs between mice and humans, which have considerable implications for vaccine development.

    DOI: 10.1016/j.immuni.2009.04.016

    Web of Science

    PubMed

    researchmap

  • Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines 査読

    Eynav Klechevsky, Maochang Liu, Rimpei Morita, Romain Banchereau, Luann Thompson-Snipes, A. Karolina Palucka, Hideki Ueno, Jacques Banchereau

    HUMAN IMMUNOLOGY   70 ( 5 )   281 - 288   2009年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE INC  

    Dendritic cells (DCs) orchestrate a repertoire of immune responses that endows resistance to infection and tolerance to self. Understanding the principles by which DCs control immunity and tolerance has provided a rich basis for studying and improving clinical outcome of human disease treatment. Several features contribute to the complexity of the DC system. Among these, plasticity and existence of subsets are prominent determinants to the quality of the elicited immune responses. Indeed, different DC subsets are distributed in peripheral tissues and the blood and display different microbial receptors, surface molecules and cytokine expression, all of which influence the immunologic outcome. The biologic raison d'etre for separate DC subsets has been the focus of many studies including our own and is being reviewed with an emphasis on human skin DCs. (C) 2009 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.humimm.2009.02.004

    Web of Science

    PubMed

    researchmap

  • A T Cell-Dependent Mechanism for the Induction of Human Mucosal Homing Immunoglobulin A-Secreting Plasmablasts 査読

    Melissa Dullaers, Dapeng Li, Yaming Xue, Ling Ni, Ingrid Gayet, Rimpei Morita, Hideki Ueno, Karolina Anna Palucka, Jacques Banchereau, SangKon Oh

    IMMUNITY   30 ( 1 )   120 - 129   2009年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CELL PRESS  

    Mucosal immunoglobulin A (IgA) secreted by local plasma cells (PCs) is a critical component of mucosal immunity. Although IgA class switching can occur at mucosal sites, high-affinity PCs are optimally generated in germinal centers (GCs) in a T cell-dependent fashion. However, how CD4(+) helper T cells induce mucosal-homing IgA-PCs remains unclear. Here, we show that transforming growth factor beta 1 (TGF beta 1) and interleukin 21 (IL-21), produced by follicular helper T cells (Tfh), synergized to generate abundant IgA-plasmablasts (PBs). In the presence of IL-21, TGF beta 1 promoted naive B cell proliferation and differentiation and overrode IL-21-induced IgG class switching in favor of IgA. Furthermore, TGF beta 1 and IL-21 downregulated CXCR5 while upregulating CCR10 on plasmablasts, enabling their exit from GCs and migration toward local mucosa. This was supported by the presence of CCR10(+)IgA(+)PBs in tonsil GCs. These findings show that Tfh contribute to mucosal IgA. Thus, mucosal vaccines should aim to induce robust Tfh responses.

    DOI: 10.1016/j.immuni.2008.11.008

    Web of Science

    PubMed

    researchmap

  • Functional specializations of human epidermal langerhans cells and CD14(+) dermal dendritic cells 査読

    Eynav Klechevsky, Rimpei Morita, Maochang Liu, Yanying Cao, Sebastien Coquery, LuAnn Thompson-Snipes, Francine Briere, Damien Chaussabel, Gerard Zurawski, A. Karolina Palucka, Yoram Reiter, Jacques Banchereau, Hideki Ueno

    IMMUNITY   29 ( 3 )   497 - 510   2008年9月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CELL PRESS  

    Little is known about the functional differences between the human skin myeloid dendritic cell (DC) subsets, epidermal CD207(+) Langerhans cells (LCs) and dermal CD14(+) DCs. We showed that CD14(+) DCs primed CD4(+) T cells into cells that induce naive B cells to switch isotype and become plasma cells. In contrast, LCs preferentially induced the differentiation of CD4(+) T cells secreting T helper 2 (Th2) cell cytokines and were efficient at priming and cross-priming naive CD8(+) T cells. A third DC population, CD14(-)CD207(-)CD1a(+) DC, which resides in the dermis, could activate CD8(+) T cells better than CD14(+) DCs but less efficiently than LCs. Thus, the human skin displays three DC subsets, two of which, i.e., CD14(+) DCs and LCs, display functional specializations, the preferential activation of humoral and cellular immunity, respectively.

    DOI: 10.1016/j.immuni.2008.07.013

    Web of Science

    PubMed

    researchmap

  • Nitric oxide inhibits IFN-alpha production of human plasmacytoid dendritic cells partly via a guanosine 3',5'-cyclic monophosphate-dependent pathway. 査読

    Morita R, Uchiyama T, Hori T

    Journal of immunology (Baltimore, Md. : 1950)   175 ( 2 )   806 - 812   2005年7月

     詳細を見る

    担当区分:筆頭著者  

    PubMed

    researchmap

  • Cytoplasmic and nuclear DROSHA in human villous trophoblasts

    Syunya Noguchi, Sadayuki Ohkura, Yasuyuki Negishi, Shohei Tozawa, Takami Takizawa, Rimpei Morita, Hironori Takahashi, Akihide Ohkuchi, Toshihiro Takizawa

    Journal of Reproductive Immunology   162   104189 - 104189   2024年3月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.jri.2023.104189

    researchmap

  • 胎盤・胎児発育に寄与する子宮筋層の免疫学的役割

    井野 創, 根岸 靖幸, 堀井 裕美, 小池 恵理, Flavell Richard, 鈴木 俊治, 森田 林平

    Reproductive Immunology and Biology   38 ( 1-2 )   87 - 87   2023年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生殖免疫学会  

    researchmap

  • 抗炎症作用に着目したヘパリンのマウス流早産防止能の検討

    徳永 朱那, 根岸 靖幸, 市川 智子, 渡邉 貴美, 井野 創, 堀井 裕美, 鈴木 俊治, 森田 林平

    Reproductive Immunology and Biology   38 ( 1-2 )   78 - 78   2023年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生殖免疫学会  

    researchmap

  • TSLP in DRG neurons causes the development of neuropathic pain through T cells. 国際誌

    Yuka Ino, Motoyo Maruyama, Masumi Shimizu, Rimpei Morita, Atsuhiro Sakamoto, Hidenori Suzuki, Atsushi Sakai

    Journal of neuroinflammation   20 ( 1 )   200 - 200   2023年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    BACKGROUND: Peripheral nerve injury to dorsal root ganglion (DRG) neurons develops intractable neuropathic pain via induction of neuroinflammation. However, neuropathic pain is rare in the early life of rodents. Here, we aimed to identify a novel therapeutic target for neuropathic pain in adults by comprehensively analyzing the difference of gene expression changes between infant and adult rats after nerve injury. METHODS: A neuropathic pain model was produced in neonatal and young adult rats by spared nerve injury. Nerve injury-induced gene expression changes in the dorsal root ganglion (DRG) were examined using RNA sequencing. Thymic stromal lymphopoietin (TSLP) and its siRNA were intrathecally injected. T cells were examined using immunofluorescence and were reduced by systemic administration of FTY720. RESULTS: Differences in changes in the transcriptome in injured DRG between infant and adult rats were most associated with immunological functions. Notably, TSLP was markedly upregulated in DRG neurons in adult rats, but not in infant rats. TSLP caused mechanical allodynia in adult rats, whereas TSLP knockdown suppressed the development of neuropathic pain. TSLP promoted the infiltration of T cells into the injured DRG and organized the expressions of multiple factors that regulate T cells. Accordingly, TSLP caused mechanical allodynia through T cells in the DRG. CONCLUSION: This study demonstrated that TSLP is causally involved in the development of neuropathic pain through T cell recruitment.

    DOI: 10.1186/s12974-023-02882-y

    PubMed

    researchmap

  • Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells. 国際誌

    Marenori Kojima, Katsuya Suzuki, Masaru Takeshita, Masaki Ohyagi, Mana Iizuka, Humitsugu Yamane, Keiko Koga, Taku Kouro, Yoshiaki Kassai, Tomoki Yoshihara, Ryutaro Adachi, Kentarou Hashikami, Yuichiro Ota, Keiko Yoshimoto, Yuko Kaneko, Rimpei Morita, Akihiko Yoshimura, Tsutomu Takeuchi

    Communications biology   6 ( 1 )   500 - 500   2023年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    T cells play important roles in autoimmune diseases, but it remains unclear how to optimally manipulate them. We focused on the T cell immunoreceptor with Ig and ITIM domains (TIGIT), a coinhibitory molecule that regulates and is expressed in T cells. In autoimmune diseases, the association between TIGIT-expressing cells and pathogenesis and the function of human-TIGIT (hu-TIGIT) signalling modification have not been fully elucidated. Here we generated anti-hu-TIGIT agonistic monoclonal antibodies (mAbs) and generated hu-TIGIT knock-in mice to accurately evaluate the efficacy of mAb function. Our mAb suppressed the activation of CD4+ T cells, especially follicular helper T and peripheral helper T cells that highly expressed TIGIT, and enhanced the suppressive function of naïve regulatory T cells. These results indicate that our mAb has advantages in restoring the imbalance of T cells that are activated in autoimmune diseases and suggest potential clinical applications for anti-hu-TIGIT agonistic mAbs as therapeutic agents.

    DOI: 10.1038/s42003-023-04874-3

    PubMed

    researchmap

  • Characterization of Megabat-favored, CA-dependent Susceptibility to Retrovirus Infection 査読 国際誌

    Sadayuki Ohkura, Masayuki Horie, Masumi Shimizu, So Nakagawa, Haruka Osanai, Yoshitaka Miyagawa, Rimpei Morita

    Journal of Virology   e0180322   2023年

     詳細を見る

    担当区分:最終著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The isolation of the Koala retrovirus-like virus from Australian megabats and the identification of endogenous retroviruses in the bat genome have raised questions on bat susceptibility to retroviruses in general. To answer this, we studied the susceptibility of 12 cell lines from 11 bat species to four well-studied retroviruses (human and simian immunodeficiency viruses [HIV and SIV] and murine leukemia viruses [B- and N-MLV]). Systematic comparison of retroviral susceptibility among bats revealed that megabat cell lines were overall less susceptible to the four retroviruses than microbat cell lines, particularly to HIV-1 infection, whereas lineage-specific differences were observed for MLV susceptibility. Quantitative PCR of reverse transcription (RT) products, infection in heterokaryon cells, and point mutation analysis of the capsid (CA) revealed that (i) HIV-1 and MLV replication were blocked at the nuclear transport of the pre-integration complexes and before and/or during RT, respectively, and (ii) the observed lineage-specific restriction can be attributed to a dominant cellular factor constrained by specific positions in CA. Investigation of bat homologs of the three previously reported post-entry restriction factors constrained by the same residues in CA, tripartite motif-protein 5α (TRIM5α), myxovirus resistance 2/B (Mx2/MxB), and carboxy terminus-truncated cleavage and polyadenylation factor 6 (CPSF6-358), demonstrated poor anti-HIV-1 activity in megabat cells, whereas megabat TRIM5α restricted MLV infection, suggesting that the major known CA-dependent restriction factors were not dominant in the observed lineage-specific susceptibility to HIV-1 in bat cells. Therefore, HIV-1 susceptibility of megabat cells may be determined in a manner distinct from that of primate cells. IMPORTANCE Recent studies have demonstrated the circulation of gammaretroviruses among megabats in Australia and the bats' resistance to HIV-1 infection; however, the origins of these viruses in megabats and the contribution of bats to retrovirus spread to other mammalian species remains unclear. To determine the intrinsic susceptibility of bat cells to HIV-1 infection, we investigated 12 cell lines isolated from 11 bat species. We report that lineage-specific retrovirus restriction in the bat cell lines can be attributed to CA-dependent factors. However, in the megabat cell lines examined, factors known to bind capsid and block infection in primate cell culture, including homologs of TRIM5α, Mx2/MxB, and CPSF6, failed to exhibit significant anti-HIV-1 activities. These results suggested that the HIV-1 susceptibility of megabat cells occurs in a manner distinct from that of primate cells, where cellular factors, other than major known CA-dependent restriction factors, with lineage-specific functions could recognize retroviral proteins in megabats.

    DOI: 10.1128/jvi.01803-22

    PubMed

    researchmap

  • CD8+ T Cell-Mediated Therapeutic Antitumor Effect of an Herbal Mixture Containing Ganoderma lucidum. 国際誌

    Shun Takaku, Masumi Shimizu, Rimpei Morita

    Evidence-based complementary and alternative medicine : eCAM   2023   9630816 - 9630816   2023年

     詳細を見る

    担当区分:最終著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Although Kampo-a traditional Japanese herbal medicine-contributes in the control of tumor growth in vivo in experimental animals, most of the antitumor effects are prophylactic and not therapeutic. In this study, we determined whether oral administration of an herbal mixture containing Ganoderma lucidum (WTMCGEP; Wisteria floribunda, Trapae fructus, Myristica fragrans, Coicis semen, Ganoderma lucidum, Elfvingia applanata, and Punica granatum), anecdotally used in Japan for the palliative care of patients with cancer, exhibits a therapeutic effect on tumor growth in vivo in a hypodermic murine CT26 colorectal tumor model. An in vitro tumor assay revealed that WTMCGEP extract has some direct influence over suppression of tumor growth. In wild-type BALB/c mice, WTMCGEP did not show any antitumor effect in vivo. However, in BALB-CD1d-/- mice with partly mitigated immunosuppression by reason of them being devoid of both antitumoral type I and immunosuppressive type II natural killer T (NKT) cells, WTMCGEP therapeutically suppressed tumor growth. CD8+ T cell depletion significantly accelerated tumor growth in WTMCGEP mice; therefore, its antitumor activity was primarily in a CD8+ T cell-dependent manner. Regarding immunosuppressive cells in tumor-bearing CD1d-/- mice, WTMCGEP did not influence the abundance of tumor-infiltrating CD4+ and Forkhead box protein 3+ regulatory T cells. However, it reduced both intratumoral and splenic Ly6G+ Ly6Clo polymorphonuclear myeloid-derived suppressor cells, which were most likely involved in tumor growth inhibition related to higher frequency of intratumoral CD107a+ CD8+ T cells in these mice. Overall, these data illustrate that the deficiency of NKT cells urges WTMCGEP to exert a therapeutic antitumor effect mainly through CD8+ T cells. Our efforts are the first to scientifically demonstrate the WTMCGEP's contribution to tumor immunity.

    DOI: 10.1155/2023/9630816

    PubMed

    researchmap

  • 炎症性サイトカインIL-18は正常な胎盤形成および胎児発育に寄与する

    井野 創, 堀井 裕美, 根岸 靖幸, 森田 林平, 鈴木 俊治

    日本医科大学医学会雑誌   18 ( 4 )   468 - 469   2022年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本医科大学医学会  

    researchmap

  • 炎症性サイトカインIL-18は正常な胎盤形成および胎児発育を促進する

    井野 創, 堀井 裕美, 根岸 靖幸, 小池 恵理, 鈴木 俊治, 森田 林平

    Reproductive Immunology and Biology   37 ( 1-2 )   110 - 110   2022年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生殖免疫学会  

    researchmap

  • プロゲステロンの流早産予防効果 その作用点と抗炎症効果の免疫学的機序

    飯田 彩実, 根岸 靖幸, 井野 創, 堀井 裕美, 島 義雄, 鈴木 俊治, 森田 林平

    日本臨床免疫学会総会プログラム・抄録集   50回   73 - 73   2022年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本臨床免疫学会  

    researchmap

  • Japanese Kampo Medicine Juzentaihoto Improves Antiviral Cellular Immunity in Tumour-Bearing Hosts

    Shun Takaku, Masumi Shimizu, Rimpei Morita

    Evidence-Based Complementary and Alternative Medicine   2022   1 - 9   2022年8月

     詳細を見る

    担当区分:最終著者   掲載種別:研究論文(学術雑誌)   出版者・発行元:Hindawi Limited  

    Global and antigen-independent immunosuppression by growing tumours can cause life-threating damage when concurrent with an infection in tumour-bearing hosts. In the present study, we investigated whether the oral administration of the Japanese traditional herbal (Kampo) medicine, juzentaihoto (JTT), plays a role in the improvement of antiviral cellular immunity in tumour-bearing hosts. Female BALB/c mice subcutaneously injected with murine colorectal cancer CT26 cells fed a control or JTT diet were inoculated with recombinant vaccinia virus expressing human immunodeficiency virus-1 glycoprotein 160 (vSC25). At 7 days postinfection, anti-vSC25 cellular immunity was evaluated by measuring the abundance of splenic virus-specific CD8+ T cells. JTT had no impact on CT26 tumour growth in vivo. Surprisingly, JTT augmented anti-vSC25 cellular immunity in CT26-bearing mice. Depletion of either CD25+ regulatory T (Treg) cells or myeloid-derived suppressor cells (MDSCs) also enhanced anti-vSC25 cellular immunity in tumour-bearing mice but had no therapeutic benefit against tumour growth. However, JTT had no impact on the abundance of these immunosuppressive cells. Overall, our data indicates that JTT contributes to the improvement of anti-vSC25 cellular immunity in tumour-bearing hosts possibly via a mechanism independent of CD25+ Treg cells and MDSCs, suggesting that this Kampo medicine can act as a promising antiviral adjuvant in an immunosuppressive state caused by tumours.

    DOI: 10.1155/2022/6122955

    researchmap

    その他リンク: http://downloads.hindawi.com/journals/ecam/2022/6122955.xml

  • 早産発症の免疫学的アプローチ 絨毛膜羊膜炎の有無による免疫細胞動態の相違

    根岸 靖幸, 島 義雄, 加藤 雅彦, 井野 創, 堀井 裕美, 鈴木 俊治, 森田 林平

    日本産婦人科感染症学会誌   6 ( 1 )   88 - 88   2022年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本産婦人科感染症学会  

    researchmap

  • Placenta-specific lncRNA 1600012P17Rik is expressed in spongiotrophoblast and glycogen trophoblast cells of mouse placenta

    Junxiao Wang, Syunya Noguchi, Takami Takizawa, Yasuyuki Negishi, Rimpei Morita, Shan-Shun Luo, Toshihiro Takizawa

    Histochemistry and Cell Biology   2022年4月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Springer Science and Business Media LLC  

    DOI: 10.1007/s00418-022-02109-w

    researchmap

    その他リンク: https://link.springer.com/article/10.1007/s00418-022-02109-w/fulltext.html

  • Alcohol consumption induces murine osteoporosis by downregulation of natural killer T-like cell activity. 国際誌

    Munehiro Naruo, Yasuyuki Negishi, Takahisa Okuda, Midori Katsuyama, Ken Okazaki, Rimpei Morita

    Immunity, inflammation and disease   2021年7月

     詳細を見る

    担当区分:最終著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    INTRODUCTION: Chronic alcohol consumption (CAC) can induce several deleterious effects on the body, including the promotion of osteoporosis; however, the immunological mechanism underlying alcohol-induced osteoporosis is still unclear. METHODS: We administered alcohol to mice for 4 weeks as the experimental CAC model and analyzed the bone and immune cells that are located in the vicinity of a bone. RESULTS: IL-4 is known to be a suppressive factor for osteoclastogenesis, and we found that natural killer T (NKT)-like cells, which showed NK1.1-positive, CD3-positive, and α-galactosylceramide-loaded CD1d tetramer-negative, produced IL-4 more effectively than CD4+ T and natural killer (NK) cells. The alcohol consumption facilitated a significant decrease of bone mineral density with the upregulation of nuclear factor of activated T cells 1 and receptor activator of NF-κB ligand expression. Meanwhile, we confirmed that alcohol consumption suppressed the activity of antigen-presenting cells (APCs) and NKT-like cells, leading to decreased IL-4 secretion. Moreover, these harmful effects of alcohol consumption were reduced by simultaneous treatment with a glycolipid antigen OCH. CONCLUSIONS: Our results indicate that the inactivation of innate immune cells, APCs, and NKT-like cells are likely to be crucial for alcohol-induced osteoporosis and provide a new therapeutic approach for preventing osteoporosis.

    DOI: 10.1002/iid3.485

    PubMed

    researchmap

  • Inflammation related to high-mobility group box-1 in endometrial ovarian cyst. 国際誌

    Mariko Ikeda, Yasuyuki Negishi, Shigeo Akira, Rimpei Morita, Toshiyuki Takeshita

    Journal of reproductive immunology   145   103292 - 103292   2021年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Endometriosis is a chronic inflammatory disease often associated with dysmenorrhea, infertility, adenomyosis, and endometrial ovarian cyst (EOC). In particular, EOC can sometimes become malignant in a longitudinal follow-up. This study aimed to investigate the involvement of high-mobility group box-1 (HMGB1) in an inflammatory milieu and the characteristics of immune cells in EOC. The samples were obtained from patients who underwent ovarian cystectomy for benign ovarian cyst. The participants were divided into two groups: patients with EOC (EOC group) and those without EOC (nEOC group). We divided a part of the removed ovary into small sections and isolated the tissue cells. Thereafter, the cytoplasmic HMGB1 levels in DCs, macrophages, and non-immune cells were analyzed by flow cytometry. We also evaluated the proportions of immune, T, NK, iNKT, NK, and regulatory T (Treg) cells. Results showed that the DCs, macrophages, and non-immune cells of EOC had significantly higher cytoplasmic HMGB1 levels than those of nEOC. The expression of CD69 and CD107a on CD8+ T and CD4+ T cells of EOC was also more enhanced than that of nEOC. Furthermore, the M2 macrophages and Tregs highly accumulated in EOC. These results indicate that HMGB1 may aggravate chronic inflammation related to T-cell activation and simultaneously facilitate development of the immunosuppressive milieu in EOCs.

    DOI: 10.1016/j.jri.2021.103292

    PubMed

    researchmap

  • Durvalumab Combined with Immunomodulatory Drugs (IMiD) Overcomes Suppression of Antitumor Responses due to IMiD-induced PD-L1 Upregulation on Myeloma Cells. 国際誌

    Mariko Ishibashi, Junichi Yamamoto, Takumi Ito, Hiroshi Handa, Mika Sunakawa-Kii, Koiti Inokuchi, Rimpei Morita, Hideto Tamura

    Molecular cancer therapeutics   2021年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We previously showed that the interaction of programmed death-ligand 1 (PD-L1) on multiple myeloma (MM) cells with PD-1 not only inhibits tumor-specific cytotoxic T-lymphocyte activity via the PD-1 signaling pathway but also induces drug resistance via PD-L1-mediated reverse signals. We here examined the regulation of PD-L1 expression by immunomodulatory drugs (IMiDs) and antimyeloma effects of the anti-PD-L1 antibody durvalumab in combination with IMiDs. IMiDs induced PD-L1 expression on IMiD-insensitive MM cells and plasma cells from patients newly diagnosed with MM. Gene-expression profiling analysis demonstrated that not only PD-L1, but also a proliferation-inducing ligand (APRIL), was enhanced by IMiDs. PD-L1 induction by IMiDs was suppressed by using the APRIL inhibitor recombinant B-cell maturation antigen (BCMA)-Ig, the antibody against BCMA, or an MEK/ERK inhibitor in in vitro and in vivo assays. In addition, its induction was abrogated in cereblon (CRBN)-knockdown MM cells, whereas PD-L1 expression was increased and strongly induced by IMiDs in Ikaros-knockdown cells. These results demonstrated that PD-L1 upregulation by IMiDs on IMiD-insensitive MM cells was induced by (i) the BCMA-APRIL pathway via IMiD-mediated induction of APRIL and (ii) Ikaros degradation mediated by CRBN, which plays a role in inhibiting PD-L1 expression. Furthermore, T-cell inhibition induced by PD-L1-upregulated cells was effectively recovered after combination treatment with durvalumab and IMiDs. PD-L1 upregulation by IMiDs on MM cells might promote aggressive myeloma behaviors and immune escape in the bone marrow microenvironment.

    DOI: 10.1158/1535-7163.MCT-20-0246

    PubMed

    researchmap

  • Thymus variants on imaging in patients with rheumatoid arthritis-Clinical and immunological significance. 国際誌

    Okinori Murata, Katsuya Suzuki, Hiroaki Sugiura, Yasushi Kondo, Masaru Takeshita, Keiko Koga, Maiko Takiguchi, Rina Kurisu, Yoshiaki Kassai, Hidekata Yasuoka, Kunihiro Yamaoka, Rimpei Morita, Akihiko Yoshimura, Tsutomu Takeuchi

    Rheumatology (Oxford, England)   60 ( 12 )   5595 - 5600   2021年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    OBJECTIVES: We sought to clarify the presence of radiographic thymus variants using a scoring system, and their association with clinical and immunological features in RA patients. METHODS: 387 RA patients randomly selected from all patients visiting our department who underwent chest CT scanning, with exclusion of patients with thymoma or thymic cyst, or age < 30 y. Thymus size and attenuation score in axial CT images were quantitatively interpreted and assessed. Associations between immunophenotype data and clinical and serological features were analysed in a subset of patients. RESULTS: Thymic enlargement was found in 76 (19.6%) patients, and a thymus attenuation score ≥ 2 was found in 50 (12.9%) patients. The score was significantly associated with antibodies to citrullinated peptide antigens (ACPA) positivity. Thymic enlargement was significantly associated with the proportions of CD4+ effector memory T cells. CONCLUSION: Radiographic thymus variants were frequently observed in RA patients, and may reflect an abnormal immune response involved in the pathogenesis of RA.

    DOI: 10.1093/rheumatology/keab164

    PubMed

    researchmap

  • Immune Functions of Signaling Lymphocytic Activation Molecule Family Molecules in Multiple Myeloma

    Mariko Ishibashi, Rimpei Morita, Hideto Tamura

    Cancers   13 ( 2 )   279 - 279   2021年1月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:MDPI AG  

    The signaling lymphocytic activation molecule (SLAM) family receptors are expressed on various immune cells and malignant plasma cells in multiple myeloma (MM) patients. In immune cells, most SLAM family molecules bind to themselves to transmit co-stimulatory signals through the recruiting adaptor proteins SLAM-associated protein (SAP) or Ewing’s sarcoma-associated transcript 2 (EAT-2), which target immunoreceptor tyrosine-based switch motifs in the cytoplasmic regions of the receptors. Notably, SLAMF2, SLAMF3, SLAMF6, and SLAMF7 are strongly and constitutively expressed on MM cells that do not express the adaptor proteins SAP and EAT-2. This review summarizes recent studies on the expression and biological functions of SLAM family receptors during the malignant progression of MM and the resulting preclinical and clinical research involving four SLAM family receptors. A better understanding of the relationship between SLAM family receptors and MM disease progression may lead to the development of novel immunotherapies for relapse prevention.

    DOI: 10.3390/cancers13020279

    researchmap

  • Inappropriate activation of invariant natural killer T cells and antigen-presenting cells with the elevation of HMGB1 in preterm births without acute chorioamnionitis. 査読 国際誌

    Masahiko Kato, Yasuyuki Negishi, Yoshio Shima, Yoshimitsu Kuwabara, Rimpei Morita, Toshiyuki Takeshita

    American journal of reproductive immunology (New York, N.Y. : 1989)   85 ( 1 )   e13330   2020年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    PROBLEM: Acute chorioamnionitis (aCAM) associated with microbial infection is a primary cause of preterm birth (PB). However, recent studies have demonstrated that innate immunity and sterile inflammation are causes of PB in the absence of aCAM. Therefore, we analyzed immune cells in the decidua of early to moderate PB without aCAM. METHOD OF STUDY: Deciduas were obtained from patients with PB at a gestational age of 24+0 to 33+6  weeks without aCAM in pathological diagnosis. The patients were divided into two groups as follows: patients with labor and/or rupture of membrane (ROM) (no aCAM with labor and/or ROM: nCAM-w-LR), and patients without labor and/or ROM (no aCAM without labor and/or ROM: nCAM-w/o-LR). The immune cells and high mobility group box 1 (HMGB1) levels in the decidua were analyzed using flow cytometry. Co-culture of CD56+ cells with dendritic cells (DCs) and macrophages obtained from the decidua was also performed in the presence of HMGB1. RESULTS: The nCAM-w-LR group demonstrated an accumulation of iNKT cells, and increased expression of HMGB1, TLR4, receptors for advanced glycation end products, and CD1d on DCs and macrophages. HMGB1 facilitated the proliferation of iNKT cells co-cultured with DCs and macrophages, which was found to be inhibited by heparin. CONCLUSIONS: Inappropriate activation of innate immune cells and increased HMGB1 expression may represent parturition signs in human pregnancy. Therefore, control of these cells and HMGB1 antigenicity may be represent a potential therapeutic target for the prevention of PB.

    DOI: 10.1111/aji.13330

    PubMed

    researchmap

  • Harmful and beneficial effects of inflammatory response on reproduction: sterile and pathogen-associated inflammation. 査読 国際誌

    Yasuyuki Negishi, Yoshio Shima, Toshiyuki Takeshita, Rimpei Morita

    Immunological medicine   1 - 18   2020年8月

     詳細を見る

    担当区分:最終著者   記述言語:英語   掲載種別:研究論文(学術雑誌)  

    In reproduction, inflammatory processes play important roles in the development of many pregnancy complications such as preterm labor/birth, recurrent pregnancy loss, recurrent implantation failure, and preeclampsia. Inflammation can be initiated by both microbial and non-microbial causes. Bacterial infection in the feto-maternal interface and uterus can provoke preterm labor/birth, miscarriage, and chronic endometritis. By contrast, inflammation without infection, or 'sterile inflammation,' can also lead to many kinds of complications, such as preterm labor/birth, miscarriage, or preeclampsia. Aberrant inflammation is facilitated by immune cells such as macrophages, dendritic cells, natural killer cells, and invariant natural killer T cells. In addition, cytokines, chemokines, and several kinds of inflammatory mediators are involved. On the other hand, appropriate inflammation is required for a successful offspring during the progression of the entire pregnancy. Herein, we discuss the relation between pregnancy and inflammation with immunological alterations. Understanding the role of inflammation in complications during pregnancy may establish new perspectives of the progress of normal pregnancy as well as treatments during pregnancy complications.

    DOI: 10.1080/25785826.2020.1809951

    PubMed

    researchmap

  • The SLAMF3 rs509749 polymorphism correlates with malignant potential in multiple myeloma 査読

    Mariko Ishibashi, Mika Sunakawa-Kii, Yuta Kaito, Ryosuke Kinoshita, Toshio Asayama, Yasuko Kuribayashi, Koiti Inokuchi, Rimpei Morita, Hideto Tamura

    Experimental Hematology   2020年8月

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Elsevier BV  

    DOI: 10.1016/j.exphem.2020.08.006

    researchmap

  • Distribution of dendritic cells in the septate uterus: An immunological perspective. 査読 国際誌

    Yasuyuki Negishi, Masahiko Kato, Shuichi Ono, Yoshimitsu Kuwabara, Rimpei Morita, Hidemi Takahashi, Toshiyuki Takeshita

    American journal of reproductive immunology (New York, N.Y. : 1989)   83 ( 6 )   e13241   2020年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    PROBLEM: Septate uterus is associated with spontaneous abortion. Surgical intervention of the uterine septa (US) is frequently performed following spontaneous abortion; however, immunological mechanisms for spontaneous abortion in patients with septate uterus remain completely unknown. METHOD OF STUDY: A total of 12 women with septate uterus who underwent hysteroscopic metroplasty and 10 women with uterine leiomyoma who underwent total hysterectomy were enrolled as the experimental and control groups, respectively. Immune cells, dendritic cells (DCs), macrophages, T cells, natural killer cells, invariant natural killer cells, and chemokine receptors in US and uterine myometrium tissue (UMT) were analyzed using flow cytometry and immunohistochemical staining. Additionally, the chemokine production of macrophage inflammatory protein 1 alpha (MIP-1α), regulated upon activation normal T-cell express sequence (RANTES), and macrophage inflammatory protein 3 beta (MIP-3β) from the viable cells obtained from the US and UMT samples was evaluated in an ex vivo study. RESULTS: The percentage of CD141+ DCs in US was significantly lower than that in UMT. Both US and UMT showed CCR1 and CCR5 expression on CD141+ DCs; however, the production of chemokines, MIP-1α, RANTES, and MIP-3β was abundant in UMT-obtained viable cells. CONCLUSION: The accumulation of CD141+ DCs was lower in US than that in UMT. This phenomenon may be caused by low chemokine productions in US. Our findings support the benefit of surgical intervention for septate uterus-that is, the elimination of inappropriate implantation sites.

    DOI: 10.1111/aji.13241

    PubMed

    researchmap

  • Notch1–JAG1 signaling induces aggressive myeloma cell behaviors 査読

    Ishibashi M, Ueda K, Imai Y, Inokuchi K, Morita R, Tamura H

    International Journal of Myeloma   2020年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    researchmap

  • A combination of check-point blockade and α-galactosylceramide elicits long-lasting suppressive effects on murine hepatoma cell growth in vivo 査読 国際誌

    Ishii K, Shimizu M, Kogo H, Tamura H, Negishi Y, Morita R, Takahashi H

    Immunobiology   151860 - 151860   2019年11月

     詳細を見る

  • 糖脂質抗原α-galactosylceramideによって活性化された樹状細胞、invariant natural killer T細胞はマウス流産を引き起こす

    根岸 靖幸, 市川 智子, 森田 林平, 竹下 俊行, 高橋 秀実

    Reproductive Immunology and Biology   34 ( 1-2 )   17 - 26   2019年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本生殖免疫学会  

    [目的]近年生殖免疫において、樹状細胞(dendritic cells:DCs)やinvariant natural killer T(iNKT)細胞など自然免疫の重要性が指摘されつつある。これまで我々は糖脂質α-galactosylceramide(α-GalCer)投与により誘導した流産マウスでは、子宮局所にDEC-205+ DCsとNK1.1+ iNKT細胞の有為な集積を報告してきたが、これら細胞の集積が流産の原因なのかそれとも結果なのかは不明であった。そこで今回我々は妊娠マウスに、予めα-GalCerを付与したDCsの養子移入を行い直接流産を誘導し得るのかを検討するとともに、原因不明ヒト流早産発症への考察を加えた。[方法]非妊娠C57BL/6(B6)マウス大腿骨、頸骨より骨髄を採取、IL-4、GM-CSFの存在下およびα-GalCer有無の条件で培養し骨髄誘導樹状細胞(bone marrow-derived DCs:BMDCs)を得た。これを磁気ビーズ法によりDEC-205+(CD205+)BMDCsとdendritic cell inhibitory receptor-2(DCIR2)+BMDCsの亜分画に分離し、それぞれ同種同系妊娠B6マウス(妊娠7.5日)に養子移入し、妊娠帰結、子宮局所の各免疫細胞をフローサイトメトリーにて解析した。また妊娠iNKT細胞欠損マウス(Jα18-/-)への、非妊娠B6マウス脾臓由来NK1.1+ iNKT細胞の養子移入により流産が誘導され得るかも検討した。[成績]DEC-205+ BMDCsはDCIR2+ BMDCsに比べα-GalCerを効率よくCD1d分子上に表出し、さらに子宮筋層、脱落膜への集積が高かった。実際α-GalCerを付与したDEC-205+ BMDCsの養子移入では高率な流産が誘導され、この際子宮局所に活性化したNK1.1+ iNKT細胞の有意な集積を認めた。さらに脾臓から採取したNK1.1+ iNKT細胞の妊娠Jα18-/-マウスへの養子移入でも、有意な流産が誘導された。[結論]α-GalCer誘導性マウス流産では、DCsやiNKT細胞が重要な働きを担う事が示唆された。自然界にはDCs-iNKT細胞系を活性化、制御しうる様々な内因性・外因性抗原が数多く存在しており、これら流早産発症に与える影響、その担い手である自然免疫の役割は今後さらに注目されると考えられる。(著者抄録)

    researchmap

    その他リンク: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2019&ichushi_jid=J05012&link_issn=&doc_id=20210405220003&doc_link_id=10.3192%2Fjsirib.34.17&url=https%3A%2F%2Fdoi.org%2F10.3192%2Fjsirib.34.17&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

  • Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell. 査読

    Takeshita M, Suzuki K, Kondo Y, Morita R, Okuzono Y, Koga K, Kassai Y, Gamo K, Takiguchi M, Kurisu R, Mototani H, Ebisuno Y, Yoshimura A, Takeuchi T

    Annals of the rheumatic diseases   78 ( 10 )   1346 - 1356   2019年10月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    DOI: 10.1136/annrheumdis-2018-214885

    Scopus

    PubMed

    researchmap

  • Significant association between joint ultrasonographic parameters and synovial inflammatory factors in rheumatoid arthritis. 査読

    Kondo Y, Suzuki K, Inoue Y, Sakata K, Takahashi C, Takeshita M, Kassai Y, Miyazaki T, Morita R, Niki Y, Kaneko Y, Yasuoka H, Yamaoka K, Yoshimura A, Takeuchi T

    Arthritis research & therapy   21 ( 1 )   14   2019年1月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    DOI: 10.1186/s13075-018-1802-x

    Scopus

    PubMed

    researchmap

  • Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission. 査読

    Tasaki S, Suzuki K, Kassai Y, Takeshita M, Murota A, Kondo Y, Ando T, Nakayama Y, Okuzono Y, Takiguchi M, Kurisu R, Miyazaki T, Yoshimoto K, Yasuoka H, Yamaoka K, Morita R, Yoshimura A, Toyoshiba H, Takeuchi T

    Nature communications   9 ( 1 )   2755   2018年7月

     詳細を見る

    掲載種別:研究論文(学術雑誌)  

    DOI: 10.1038/s41467-018-05044-4

    Scopus

    PubMed

    researchmap

  • Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren's syndrome

    Shinya Tasaki, Katsuya Suzuki, Ayumi Nishikawa, Yoshiaki Kassai, Maiko Takiguchi, Rina Kurisu, Yuumi Okuzono, Takahiro Miyazaki, Masaru Takeshita, Keiko Yoshimoto, Hidekata Yasuoka, Kunihiro Yamaoka, Kazuhiro Ikeura, Kazuyuki Tsunoda, Rimpei Morita, Akihiko Yoshimura, Hiroyoshi Toyoshiba, Tsutomu Takeuchi

    Annals of the Rheumatic Diseases   76 ( 8 )   1458 - 1466   2017年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BMJ Publishing Group  

    Objectives Multiomics study was conducted to elucidate the crucial molecular mechanisms of primary Sjögren's syndrome (SS) pathology. Methods We generated multiple data set from well-defined patients with SS, which includes whole-blood transcriptomes, serum proteomes and peripheral immunophenotyping. Based on our newly generated data, we performed an extensive bioinformatic investigation. Results Our integrative analysis identified SS gene signatures (SGS) dysregulated in widespread omics layers, including epigenomes, mRNAs and proteins. SGS predominantly involved the interferon signature and ADAMs substrates. Besides, SGS was significantly overlapped with SS-causing genes indicated by a genome-wide association study and expression trait loci analyses. Combining the molecular signatures with immunophenotypic profiles revealed that cytotoxic CD8 T cellswere associated with SGS. Further, we observed the activation of SGS in cytotoxic CD8 T cells isolated from patients with SS. Conclusions Our multiomics investigation identified gene signatures deeply associated with SS pathology and showed the involvement of cytotoxic CD8 T cells. These integrative relations across multiple layers will facilitate our understanding of SS at the system level.

    DOI: 10.1136/annrheumdis-2016-210788

    Scopus

    PubMed

    researchmap

  • Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome. 査読

    Nishikawa A, Suzuki K, Kassai Y, Gotou Y, Takiguchi M, Miyazaki T, Yoshimoto K, Yasuoka H, Yamaoka K, Morita R, Yoshimura A, Takeuchi T

    Arthritis research & therapy   18 ( 1 )   106   2016年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1186/s13075-016-1006-1

    Web of Science

    PubMed

    researchmap

  • Innate-like function of memory T-h 17 cells for enhancing endotoxin-induced acute lung inflammation through IL-22 査読

    Ryota Sakaguchi, Shunsuke Chikuma, Takashi Shichita, Rimpei Morita, Takashi Sekiya, Wenjun Ouyang, Tomomi Ueda, Hiroyuki Seki, Hiroshi Morisaki, Akihiko Yoshimura

    INTERNATIONAL IMMUNOLOGY   28 ( 5 )   233 - 243   2016年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:OXFORD UNIV PRESS  

    Lipopolysaccharide (LPS)-induced acute lung injury (ALI) is known as a mouse model of acute respiratory distress syndrome; however, the function of T-cell-derived cytokines in ALI has not yet been established. We found that LPS challenge in one lung resulted in a rapid induction of innate-type pro-inflammatory cytokines such as IL-6 and TNF-alpha, followed by the expression of T-cell-type cytokines, including IL-17, IL-22 and IFN-gamma. We discovered that IL-23 is important for ALI, since blockage of IL-23 by gene disruption or anti-IL-12/23p40 antibody treatment reduced neutrophil infiltration and inflammatory cytokine secretion into the bronchoalveolar lavage fluid (BALF). IL-23 was mostly produced from F4/80(+)CD11c(+) alveolar macrophages, and IL-23 expression was markedly reduced by the pre-treatment of mice with antibiotics, suggesting that the development of IL-23-producing macrophages required commensal bacteria. Unexpectedly, among T-cell-derived cytokines, IL-22 rather than IL-17 or IFN-gamma played a major role in LPS-induced ALI. IL-22 protein levels were higher than IL-17 in the BALF after LPS instillation, and the major source of IL-22 was memory T(h)17 cells. Lung memory CD4(+) T cells had a potential to produce IL-22 at higher levels than IL-17 in response to IL-1 beta plus IL-23 without TCR stimulation. Our study revealed an innate-like function of the lung memory T(h)17 cells that produce IL-22 in response to IL-23 and are involved in exaggeration of ALI.

    DOI: 10.1093/intimm/dxv070

    Web of Science

    PubMed

    researchmap

  • Resolution of elevated circulating regulatory T cells by corticosteroids in patients with IgG4-related dacryoadenitis and sialoadenitis 査読

    Mitsuhiro Akiyama, Katsuya Suzuki, Yoshiaki Kassai, Takahiro Miyazaki, Rimpei Morita, Akihiko Yoshimura, Tsutomu Takeuchi

    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES   19 ( 4 )   430 - 432   2016年4月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    DOI: 10.1111/1756-185X.12725

    Web of Science

    PubMed

    researchmap

  • Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis 査読

    Atsuko Murota, Katsuya Suzuki, Yoshiaki Kassai, Takahiro Miyazaki, Rimpei Morita, Yasushi Kondo, Masaru Takeshita, Yasuo Niki, Akihiko Yoshimura, Tsutomu Takeuchi

    CYTOKINE   78   87 - 93   2016年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD  

    Objectives: To conduct a comprehensive quantitative proteomics analysis of novel serum protein biomarkers based on synovitis status associated with matrix metalloproteinase-3 (MMP-3) and to determine the clinical significance of these biomarkers in rheumatoid arthritis (RA).
    Methods: Patients with untreated RA (n = 28), primary Sjogren's syndrome (pSS) (n = 30), and healthy controls (HCs) (n = 30) were enrolled for the screening assay. A total of 1128 serum proteins were analyzed using the SOMAscan'm assay. Serum levels of MMP-3 and interleukin (IL)-16 were measured using a latex turbidimetric immunoassay and ELISA at baseline and 12 weeks after treatment with methotrexate (MIX) for MIX-naive RA patients (n = 28) or with the biologics tocilizumab (TCZ) (n = 7), abatacept (ABT) (n = 11) or infliximab (n = 22) for MTX-inadequate response (IR) RA patients. Correlation analysis was conducted using Spearman's rank correlation method.
    Results: Proteomics showed that serum IL-16 levels were most positively correlated with those of MMP-3 (p = 0.51, p &lt;0.01) and were significantly increased in patients with untreated active RA compared to HCs (p &lt;0.01) or those with pSS (p &lt; 0.01). IL-16 levels decreased following treatment in both the MTX-neve and MTX-IR groups. Regarding clinical response, fluctuations in IL-16 levels were positively associated with changes in clinical indicators, particularly the Clinical Disease Activity Index (p = 0.89, p &lt;0.01) in the TCZ and ABT-treated group. However, no similar correlation was noted in MMP-3 and acute phase reactants in any groups.
    Conclusions: IL-16 was a more effective clinical parameter than MMP-3, C-reactive protein, or erythrocyte sedimentation rate in both MIX-naive and MTX-IR RA patients. IL-16 might be a useful biomarker for evaluating clinical response in RA patients. (C) 2015 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.cyto.2015.12.002

    Web of Science

    PubMed

    researchmap

  • Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1 査読

    Yasuko Hirata, Hilde Brems, Mayu Suzuki, Mitsuhiro Kanamori, Masahiro Okada, Rimpei Morita, Isabel Llano-Rivas, Toyoyuki Ose, Ludwine Messiaen, Eric Legius, Akihiko Yoshimura

    JOURNAL OF BIOLOGICAL CHEMISTRY   291 ( 7 )   3124 - 3134   2016年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Constitutional heterozygous loss-of-function mutations in the SPRED1 gene cause a phenotype known as Legius syndrome, which consists of symptoms of multiple cafe-au-lait macules, axillary freckling, learning disabilities, and macrocephaly. Legius syndrome resembles a mild neurofibromatosis type 1 (NF1) phenotype. It has been demonstrated that SPRED1 functions as a negative regulator of the Ras-ERK pathway and interacts with neurofibromin, the NF1 gene product. However, the molecular details of this interaction and the effects of the mutations identified in Legius syndrome and NF1 on this interaction have not yet been investigated. In this study, using a yeast two-hybrid system and an immunoprecipitation assay in HEK293 cells, we found that the SPRED1 EVH1 domain interacts with the N-terminal 16 amino acids and the C-terminal 20 amino acids of the GTPase-activating protein (GAP)-related domain (GRD) of neurofibromin, which form two crossing -helix coils outside the GAP domain. These regions have been shown to be dispensable for GAP activity and are not present in p120(GAP). Several mutations in these N- and C-terminal regions of the GRD in NF1 patients and pathogenic missense mutations in the EVH1 domain of SPRED1 in Legius syndrome reduced the binding affinity between the EVH1 domain and the GRD. EVH1 domain mutations with reduced binding to the GRD also disrupted the ERK suppression activity of SPRED1. These data clearly demonstrate that SPRED1 inhibits the Ras-ERK pathway by recruiting neurofibromin to Ras through the EVH1-GRD interaction, and this study also provides molecular basis for the pathogenic mutations of NF1 and Legius syndrome.

    DOI: 10.1074/jbc.M115.703710

    Web of Science

    PubMed

    researchmap

  • Comprehensive Novel Proteomic Analysis of RA Synovial Fluid Highlights the Distinct Protein Profiles of Bone and Cartilage Metabolism 査読

    Yasushi Kondo, Katsuya Suzuki, Masaru Takeshita, Yoshiaki Kassai, Keiko Koga, Yuumi Gotou, Takahiro Miyazaki, Rimpei Morita, Yasuo Niki, Atsuko Murota, Ayumi Nishikawa, Hironari Hanaoka, Yuko Kaneko, Hidekata Yasuoka, Kunihiro Yamaoka, Akihiko Yoshimura, Tsutomu Takeuchi

    ARTHRITIS & RHEUMATOLOGY   67   2015年10月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • Brief Report Number of Circulating Follicular Helper 2 T Cells Correlates With IgG4 and Interleukin-4 Levels and Plasmablast Numbers in IgG4-Related Disease 査読

    Mitsuhiro Akiyama, Katsuya Suzuki, Kunihiro Yamaoka, Hidekata Yasuoka, Masaru Takeshita, Yuko Kaneko, Harumi Kondo, Yoshiaki Kassai, Takahiro Miyazaki, Rimpei Morita, Akihiko Yoshimura, Tsutomu Takeuchi

    ARTHRITIS & RHEUMATOLOGY   67 ( 9 )   2476 - 2481   2015年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    Objective. To elucidate the pathologic role of follicular helper T (Tfh) cells and their subsets in active, untreated IgG4-related disease.
    Methods. Fifteen patients with active, untreated, biopsy-proven IgG4-related disease, 24 patients with primary Sjogren's syndrome (SS), 12 patients with allergic rhinitis, and 23 healthy controls were evaluated. Tfh cells were defined as CD3+CD4+CXCR5+CD45RA- cells. Circulating Tfh cell subsets among CXCR5+CD45RA-CD4+ T cells were defined as Tfh17 cells (CXCR3-CCR6+), Tfh1 cells (CXCR3+CCR6-), or Tfh2 cells (CXCR3-CCR6-). CD19+CD20-CD27+CD38+ cells were defined as plasmablasts. Serum cytokine levels (interleukin-4 [IL-4], IL-10, IL-21, and IL-33) were measured by cytometric bead array or enzyme-linked immunosorbent assay.
    Results. Patients with IgG4-related disease had significantly increased levels of Tfh2 cells compared to healthy controls or patients with primary SS or allergic rhinitis. Increased Tfh2 levels were strongly associated with increased serum IgG4 levels and the IgG4:IgG ratio in IgG4-related disease. A positive correlation was observed between Tfh2 counts, plasmablast counts, and serum IL-4 levels. Interestingly, levels of plasmablasts and serum IL-4 and IgG4 decreased after treatment with glucocorticoids, whereas no obvious change was observed in Tfh2 cell counts.
    Conclusion. The Tfh2 cell count was specifically increased in IgG4-related disease and was correlated with elevated serum levels of IgG4 and IL-4 and plasmablast counts. Tfh2 cells were the only component that was not affected by glucocorticoid treatment, suggesting that Tfh2 cells are the cell type implicated in IgG4-related disease.

    DOI: 10.1002/art.39209

    Web of Science

    PubMed

    researchmap

  • Suppression of Th2 and Tfh immune reactions by Nr4a receptors in mature T reg cells 査読

    Takashi Sekiya, Taisuke Kondo, Takashi Shichita, Rimpei Morita, Hiroshi Ichinose, Akihiko Yoshimura

    JOURNAL OF EXPERIMENTAL MEDICINE   212 ( 10 )   1623 - 1640   2015年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ROCKEFELLER UNIV PRESS  

    Regulatory T (T reg) cells are central mediators of immune suppression. As such, T reg cells are characterized by a distinct pattern of gene expression, which includes up-regulation of immunosuppressive genes and silencing of inflammatory cytokine genes. Although an increasing number of transcription factors that regulate T reg cells have been identified, the mechanisms by which the T reg cell-specific transcriptional program is maintained and executed remain largely unknown. The Nr4a family of nuclear orphan receptors, which we recently identified as essential for the development of T reg cells, is highly expressed in mature T reg cells as well, suggesting that Nr4a factors play important roles even beyond T reg cell development. Here, we showed that deletion of Nr4a genes specifically in T reg cells caused fatal systemic immunopathology. Nr4a-deficient T reg cells exhibited global alteration of the expression of genes which specify the T reg cell lineage, including reduction of Foxp3 and Ikzf4. Furthermore, Nr4a deficiency abrogated T reg cell suppressive activities and accelerated conversion to cells with Th2 and follicular helper T (Tfh) effector-like characteristics, with heightened expression of Th2 and Tfh cytokine genes. These findings demonstrate that Nr4a factors play crucial roles in mature T reg cells by directly controlling a genetic program indispensable for T reg cell maintenance and function.

    DOI: 10.1084/jem.20142088

    Web of Science

    PubMed

    researchmap

  • Spred1, a Suppressor of the Ras-ERK Pathway, Negatively Regulates Expansion and Function of Group 2 Innate Lymphoid Cells 査読

    Mayu Suzuki, Rimpei Morita, Yasuko Hirata, Takashi Shichita, Akihiko Yoshimura

    JOURNAL OF IMMUNOLOGY   195 ( 3 )   1273 - 1281   2015年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER ASSOC IMMUNOLOGISTS  

    Cytokines from group 2 innate lymphoid cells (ILC2s) have been implicated in acute allergic responses, such as papain-induced lung inflammation. However, the means of homeostatic regulation of ILC2s have not been established. In this study, we demonstrated that Spred1, a negative regulator of the Ras-ERK pathway, plays an important role in the proliferation and apoptosis of ILC2s and in cytokine secretion from ILC2s. Intranasal administration of papain stimulated IL-5 and IL-13 production in the lung, which was enhanced when Spred1 was deleted. In vitro, Spred1(-/-) ILC2s proliferated faster than wild type ILC2s did and produced higher levels of cytokines in response to IL-33. On the contrary, a MEK inhibitor suppressed ILC2 proliferation and cytokine production. Spred1 deficiency resulted in stabilization of GATA3, which has been shown to play essential roles in the maintenance and cytokine production of ILC2. These data suggest that Spred1 negatively regulates ILC2 development and functions through the suppression of the Ras-ERK pathway.

    DOI: 10.4049/jimmunol.1500531

    Web of Science

    PubMed

    researchmap

  • Polarization diversity of human CD4(+) stem cell memory T cells 査読

    Masaru Takeshita, Katsuya Suzuki, Yoshiaki Kassai, Maiko Takiguchi, Yusuke Nakayama, Yuki Otomo, Rimpei Morita, Takahiro Miyazaki, Akihiko Yoshimura, Tsutonnu Takeuchi

    CLINICAL IMMUNOLOGY   159 ( 1 )   107 - 117   2015年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    T cells are considered to develop through three stages, from naive T (Tn) into central memory T (Tcm) and finally into effector memory T (Tem). Among the subsets of Tn, stem cell memory T (Tscm) were recently found to be the least developed memory subset. While this subset was revealed to possess self-reproducibility and multipotentiality, little is known about the relationship between development and polarity. We conducted transcriptome analysis of human CD4(+) T subsets and found that Tscm was a clearly distinct subset, located between Tn and Tcm. Surface antigen analysis and differentiation assay showed that the flexibility of polarity and the cytokine production progressively changed as the differentiation of CD4(+) T cells advanced. Interestingly, we found that most cells of the CD45RO(-)CCR7(+)CCR6(+) subset, hitherto considered the naive precursor of Th17, were in fact Tscm. These findings may advance our understanding of the highly heterogeneous human helper T cells. (C) 2015 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.clim.2015.04.010

    Web of Science

    PubMed

    researchmap

  • Aryl hydrocarbon receptor protects against bacterial infection by promoting macrophage survival and reactive oxygen species production 査読

    Akihiro Kimura, Hiromi Abe, Sanae Tsuruta, Sayuri Chiba, Yoshiaki Fujii-Kuriyama, Takashi Sekiya, Rimpei Morita, Akihiko Yoshimura

    INTERNATIONAL IMMUNOLOGY   26 ( 4 )   209 - 220   2014年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:OXFORD UNIV PRESS  

    The AhR protects against Listeria infection by enhancing macrophage survival and ROS production.Aryl hydrocarbon receptor (AhR) is crucial for various immune responses. The relationship between AhR and infection with the intracellular bacteria Listeria monocytogenes (LM) is poorly understood. Here, we show that in response to LM infection, AhR is required for bacterial clearance by promoting macrophage survival and reactive oxygen species (ROS) production. AhR-deficient mice were more susceptible to listeriosis, and AhR deficiency enhances bacterial growth in vivo and in vitro. On the other hand, pro-inflammatory cytokines were increased in AhR-deficient macrophages infected with LM despite enhanced susceptibility to LM infection in AhR-deficient mice. Subsequent studies demonstrate that AhR protects against macrophage cell death induced by LM infection through the induction of the antiapoptotic factor, the apoptosis inhibitor of macrophages, which promotes macrophage survival in the setting of LM infection. Furthermore, AhR promotes ROS production for bacterial clearance. Our results demonstrate that AhR is essential to the resistance against LM infection as it promotes macrophage survival and ROS production. This suggests that the activation of AhR by its ligands may be an effective strategy against listeriosis.

    DOI: 10.1093/intimm/dxt067

    Web of Science

    PubMed

    researchmap

  • Aryl hydrocarbon receptor plays protective roles in ConA-induced hepatic injury by both suppressing IFN-γ expression and inducing IL-22. 査読

    Abe H, Kimura A, Tsuruta S, Fukaya T, Sakaguchi R, Morita R, Sekiya T, Shichita T, Chayama K, Fujii-Kuriyama Y, Yoshimura A

    International immunology   26 ( 3 )   129 - 137   2014年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1093/intimm/dxt049

    Web of Science

    PubMed

    researchmap

  • Prevention of Allogeneic Cardiac Graft Rejection by Transfer of Ex Vivo Expanded Antigen-Specific Regulatory T-Cells 査読

    Fumika Takasato, Rimpei Morita, Takashi Schichita, Takashi Sekiya, Yasuhide Morikawa, Tatsuo Kuroda, Masanori Niimi, Akihiko Yoshimura

    PLOS ONE   9 ( 2 )   e87722   2014年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    The rate of graft survival has dramatically increased using calcineurin inhibitors, however chronic graft rejection and risk of infection are difficult to manage. Induction of allograft-specific regulatory T-cells (Tregs) is considered an ideal way to achieve long-term tolerance for allografts. However, efficient in vitro methods for developing allograft-specific Tregs which is applicable to MHC full-mismatched cardiac transplant models have not been established. We compared antigen-nonspecific polyclonal-induced Tregs (iTregs) as well as antigen-specific iTregs and thymus-derived Tregs (nTregs) that were expanded via direct and indirect pathways. We found that iTregs induced via the indirect pathway had the greatest ability to prolong graft survival and suppress angiitis. Antigen-specific iTregs generated ex vivo via both direct and indirect pathways using dendritic cells from F1 mice also induced long-term engraftment without using MHC peptides. In antigen-specific Treg transferred models, activation of dendritic cells and allograft-specific CTL generation were suppressed. The present study demonstrated the potential of ex vivo antigen-specific Treg expansion for clinical cell-based therapeutic approaches to induce lifelong immunological tolerance for allogeneic cardiac transplants.

    DOI: 10.1371/journal.pone.0087722

    Web of Science

    PubMed

    researchmap

  • Th17 Cells Carrying TCR Recognizing Epidermal Autoantigen Induce Psoriasis-like Skin Inflammation 査読

    Shuhei Nishimoto, Hitoshi Kotani, Sanae Tsuruta, Nana Shimizu, Minako Ito, Takashi Shichita, Rimpei Morita, Hayato Takahashi, Masayuki Amagai, Akihiko Yoshimura

    JOURNAL OF IMMUNOLOGY   191 ( 6 )   3065 - 3072   2013年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER ASSOC IMMUNOLOGISTS  

    Psoriasis is considered a Th17-type autoimmune skin inflammatory disease; however, involvement of an autoantigen-specific TCR has not been established. In this study, we show that psoriasis-like skin inflammation can be induced by autoreactive Th17 cells. We previously developed the desmoglein 3-specific TCR-transgenic (Dsg3H1) mouse, in which CD4(+) T cells recognize physiological epidermal autoantigen. T cells from Dsg3H1 mice were polarized into Th17 cells in vitro and then adoptively transferred into Rag2(-/-) mice. Dsg3H1-Th17 cells induced severe psoriasis-like skin inflammation within 2 wk after transfer in the tissues in which desmoglein 3 is expressed. Such pathology was not observed when wild-type Th17 cells or Th1-skewed Dsg3H1 T cells were transferred, and it was strongly suppressed by anti-IL-12/23 and anti-IL-17 Abs. Although IFN-gamma(+)/IL-17(+) T cells accumulated in the skin lesions of mice that received Dsg3H1-Th17 cells, IFN-gamma-deficient Dsg3H1-Th17 cells were fully pathogenic. These results demonstrate that cutaneous psoriasis-like immunopathology can be developed by epidermis-specific recognition of Th17 cells, which is strictly dependent on IL-17 but not IFN-gamma.

    DOI: 10.4049/jimmunol.1300348

    Web of Science

    PubMed

    researchmap

  • TRAF6 Is Essential for Maintenance of Regulatory T Cells That Suppress Th2 Type Autoimmunity 査読

    Go Muto, Hitoshi Kotani, Taisuke Kondo, Rimpei Morita, Sanae Tsuruta, Takashi Kobayashi, Herve Luche, Hans Joerg Fehling, Matthew Walsh, Yongwon Choi, Akihiko Yoshimura

    PLOS ONE   8 ( 9 )   e74639   2013年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:PUBLIC LIBRARY SCIENCE  

    Regulatory T cells (Tregs) maintain immune homeostasis by limiting inflammatory responses. TRAF6 plays a key role in the regulation of innate and adaptive immunity by mediating signals from various receptors including the T-cell receptor (TCR). T cell-specific deletion of TRAF6 has been shown to induce multiorgan inflammatory disease, but the role of TRAF6 in Tregs remains to be investigated. Here, we generated Treg-specific TRAF6-deficient mice using Foxp3-Cre and TRAF6-flox mice. Treg-specific TRAF6-deficient (cKO) mice developed allergic skin diseases, arthritis, lymphadenopathy and hyper IgE phenotypes. Although TRAF6-deficient Tregs possess similar in vitro suppression activity compared to wild-type Tregs, TRAF6-deficient Tregs did not suppress colitis in lymphopenic mice very efficiently due to reduced number of Foxp3-positive cells. In addition, the fraction of TRAF6-deficient Tregs was reduced compared with wild-type Tregs in female cKO mice without inflammation. Moreover, adoptive transfer of Foxp3(+) Tregs into Rag2(-/-) mice revealed that TRAF6-deficient Tregs converted into Foxp3-cells more rapidly than WT Tregs under lymphopenic conditions. Fate-mapping analysis also revealed that conversion of Tregs from Foxp3(+) to Foxp3(-) (exFoxp3 cells) was accelerated in TRAF6-deficient Tregs. These data indicate that TRAF6 in Tregs plays important roles in the maintenance of Foxp3 in Tregs and in the suppression of pathogenic Th2 type conversion of Tregs.

    DOI: 10.1371/journal.pone.0074639

    Web of Science

    PubMed

    researchmap

  • Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis 査読

    Takashi Sekiya, Ikkou Kashiwagi, Rei Yoshida, Tomohiro Fukaya, Rimpei Morita, Akihiro Kimura, Hiroshi Ichinose, Daniel Metzger, Pierre Chambon, Akihiko Yoshimura

    NATURE IMMUNOLOGY   14 ( 3 )   230 - 237   2013年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Regulatory T cells (T-reg cells) develop from progenitor thymocytes after the engagement of T cell antigen receptors (TCRs) with high-affinity ligands, but the underlying molecular mechanisms are still unclear. Here we show that the Nr4a nuclear receptors, which are encoded by immediate-early genes upregulated by TCR stimulation in thymocytes, have essential roles in T-reg cell development. Mice that lacked all Nr4a factors could not produce T-reg cells and died early owing to systemic autoimmunity. Nr4a receptors directly activated the promoter of the gene encoding the transcription factor Foxp3, and forced activation of Nr4a receptors bypassed low-strength TCR signaling to drive the T-reg cell developmental program. Our results suggest that Nr4a receptors have key roles in determining CD4(+) T cell fates in the thymus and thus contribute to immune homeostasis.

    DOI: 10.1038/ni.2520

    Web of Science

    PubMed

    researchmap

  • IL-23-independent induction of IL-17 from γδT cells and innate lymphoid cells promotes experimental intraocular neovascularization. 査読

    Hasegawa E, Sonoda KH, Shichita T, Morita R, Sekiya T, Kimura A, Oshima Y, Takeda A, Yoshimura T, Yoshida S, Ishibashi T, Yoshimura A

    Journal of immunology (Baltimore, Md. : 1950)   190 ( 4 )   1778 - 1787   2013年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.4049/jimmunol.1202495

    Web of Science

    PubMed

    researchmap

  • Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain 査読

    Takashi Shichita, Eiichi Hasegawa, Akihiro Kimura, Rimpei Morita, Ryota Sakaguchi, Ichiro Takada, Takashi Sekiya, Hiroaki Ooboshi, Takanari Kitazono, Toru Yanagawa, Tetsuro Ishii, Hideo Takahashi, Shuji Mori, Masahiro Nishibori, Kazumichi Kuroda, Shizuo Akira, Kensuke Miyake, Akihiko Yoshimura

    NATURE MEDICINE   18 ( 6 )   911 - +   2012年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Post-ischemic inflammation is an essential step in the progression of brain ischemia-reperfusion injury. However, the mechanism that activates infiltrating macrophages in the ischemic brain remains to be clarified. Here we demonstrate that peroxiredoxin (Prx) family proteins released extracellularly from necrotic brain cells induce expression of inflammatory cytokines including interleukin-23 in macrophages through activation of Toll-like receptor 2 (TLR2) and TLR4, thereby promoting neural cell death, even though intracellular Prxs have been shown to be neuroprotective. The extracellular release of Prxs in the ischemic core occurred 12 h after stroke onset, and neutralization of extracellular Prxs with antibodies suppressed inflammatory cytokine expression and infarct volume growth. In contrast, high mobility group box 1 (HMGB1), a well-known damage-associated molecular pattern molecule, was released before Prx and had a limited role in post-ischemic macrophage activation. We thus propose that extracellular Prxs are previously unknown danger signals in the ischemic brain and that its blocking agents are potent neuroprotective tools.

    DOI: 10.1038/nm.2749

    Web of Science

    PubMed

    researchmap

  • Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways 査読

    Yuki Sugiyama, Kyosuke Kakoi, Akihiro Kimura, Ichiro Takada, Ikko Kashiwagi, Yu Wakabayashi, Rimpei Morita, Masatoshi Nomura, Akihiko Yoshimura

    INTERNATIONAL IMMUNOLOGY   24 ( 4 )   253 - 265   2012年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:OXFORD UNIV PRESS  

    Although transforming growth factor (TGF)-beta 1 is a well-known immunosuppressive cytokine, little is known about the role of its downstream transcription factors, Smad2 and Smad3, in the suppression of macrophage activation. Previous studies have demonstrated that Smad3 is critical for the suppression of LPS-mediated inducible nitric oxide (NO) synthase (iNOS) induction, although the role of Smad2 remains to be investigated. In this study, we found that iNOS induction was enhanced in Smad2-deficient bone marrow-derived macrophages (BMDMs) and peritoneal macrophages in vitro and tumor-associated macrophages in vivo, compared with wild-type (WT) macrophages. However, TGF-beta 1 still suppressed iNOS induction in Smad2-deficient macrophages. In Smad2/3 double knockout (KO) (Smad2/3 DKO) BMDMs, LPS-mediated NO/iNOS induction was more strongly elevated than in Smad2 or Smad3 single KO BMDMs, and its suppression by exogenous TGF-beta 1 was severely impaired. These data suggest that Smad2 and Smad3 redundantly regulate iNOS induction. Similarly, the production of IL-6 and TNF alpha, but not IL-10 was augmented in Smad2/3 DKO BMDMs, suggesting that Smad2 and Smad3 also redundantly suppressed some cytokines production. In Smad2/3 DKO macrophages, TLR3- as well as TLR4-mediated IRF3 activation and IFN-beta production were strongly augmented, which resulted in hyper STAT1 phosphorylation. Furthermore, IFN-beta- and IFN-gamma-induced iNOS induction in the absence of TLR signaling and STAT1 transcriptional activity were augmented in Smad2/3 DKO BMDMs. These results suggest that Smad2 and Smad3 negatively regulate iNOS induction in macrophages by suppressing multiple steps in the IRF3-IFN-beta-STAT1 pathway.

    DOI: 10.1093/intimm/dxr126

    Web of Science

    PubMed

    researchmap

  • Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation 査読

    Hideyuki Yoshida, Akihiro Kimura, Tomohiro Fukaya, Takashi Sekiya, Rimpei Morita, Takashi Shichita, Hiromasa Inoue, Akihiko Yoshimura

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   418 ( 2 )   234 - 240   2012年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Th17 cells, which have been implicated in autoimmune diseases, require STAT3 signaling activated by IL-6 or IL-23 for their development. Other Th1 and Th2 cytokines such as IL-2, IFN-gamma and IL-4 strongly suppress Th17 development. Recently, CP-690,550 (tofacitinib), originally developed as a JAK3 inhibitor, has been shown to be effective in phase III clinical trials of rheumatoid arthritis and collagen-induced arthritis (CIA) models, but the precise mechanism of the effect, especially with respect to Th17 cells, is poorly understood. To our surprise, a low dose CP-690,550 was found to accelerate the onset of experimental autoimmune encephalomyelitis (EAE) at a concentration that suppressed CIA. At an early stage after immunization, more IL-17 production was observed in 15 mg/kg body weight CP-690,550-treated mice than in untreated mice. In vitro, CP-690,550 inhibited both Th1 and Th2 development, while promoting Th17 differentiation at 10-50 nM concentrations. Enhancement of Th17 by CP-690,550 is probably due to suppression of IL-2 signaling, because anti-IL-2 antibodies cancel the Th17-promoting effect of CP-690,550. CP-690,550 selectively inhibited IFN-induced STAT1, IL-4-induced STAT6 and IL-2-induced STAT5 at 3-30 nM, while suppression of IL-6-induced STAT3 phosphorylation required a concentration greater than 100 nM. In HEK293T cells, CP-690,550 less effectively suppressed JAK1-mediated STAT3 phosphorylation compared with JAK3. These results suggest that CP-690,550 has a different effects among JAKs and STATs, thereby affecting helper T cell differentiation, and murine autoimmune disease models. (C) 2012 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2011.12.156

    Web of Science

    PubMed

    researchmap

  • Pyridone 6, a Pan-JAK Inhibitor, Ameliorates Allergic Skin Inflammation of NC/Nga Mice via Suppression of Th2 and Enhancement of Th17 査読

    Ryusuke Nakagawa, Hideyuki Yoshida, Mayako Asakawa, Taiga Tamiya, Naoko Inoue, Rimpei Morita, Hiromasa Inoue, Atsuhito Nakao, Akihiko Yoshimura

    JOURNAL OF IMMUNOLOGY   187 ( 9 )   4611 - 4620   2011年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER ASSOC IMMUNOLOGISTS  

    Atopic dermatitis (AD) is a common pruritic inflammatory disease triggered by a defective skin barrier and immunodysregulation. AD has been considered a typical example of a Th2 response associated with allergic disease. In the early phases of the disease, symptoms include IgE hyperproduction, eosinophil accumulation, and mast cell activation; in the chronic phase, a Th1-dominant immune response is also observed at the sites of AD skin lesions. The role of IL-17-producing Th (Th17) cells in AD has not been established. In the current study, we found that pyridone 6 (P6), a pan-JAK inhibitor, delayed the onset and reduced the magnitude of skin disease in an AD-like skin-disease model of NC/Nga mice. P6 reduced IFN-gamma and IL-13, whereas it enhanced IL-17 and IL-22 expression. In vitro, P6 also inhibited both Th1 and Th2 development, whereas it promoted Th17 differentiation from naive T cells when present within a certain range of concentrations. This was probably because P6 strongly inhibited STAT1, STAT5, and STAT6 phosphorylation, whereas STAT3 phosphorylation was less efficiently suppressed by P6 at the same concentration. Furthermore, IL-22 protects keratinocytes from apoptosis induced by IFN-gamma, and administration of IL-17 and IL-22 partially ameliorated skin diseases in NC/Nga mice. These results suggested that the JAK inhibitor P6 is therapeutic for AD by modulating the balance of Th2 and Th17. The Journal of Immunology, 2011, 187: 4611-4620.

    DOI: 10.4049/jimmunol.1100649

    Web of Science

    PubMed

    researchmap

  • Histone 3 lysine 9 (H3K9) methyltransferase recruitment to the interleukin-2 (IL-2) promoter is a mechanism of suppression of IL-2 transcription by the transforming growth factor-β-Smad pathway. 査読

    Wakabayashi Y, Tamiya T, Takada I, Fukaya T, Sugiyama Y, Inoue N, Kimura A, Morita R, Kashiwagi I, Takimoto T, Nomura M, Yoshimura A

    The Journal of biological chemistry   286 ( 41 )   35456 - 35465   2011年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1074/jbc.M111.236794

    Web of Science

    PubMed

    researchmap

  • Suppression of SOCS3 in macrophages prevents cancer metastasis by modifying macrophage phase and MCP2/CCL8 induction 査読

    Kiyokazu Hiwatashi, Taiga Tamiya, Eiichi Hasegawa, Tomohiro Fukaya, Masayuki Hashimoto, Kyosuke Kakoi, Ikko Kashiwagi, Akihiro Kimura, Naoko Inoue, Rimpei Morita, Hideo Yasukawa, Akihiko Yoshimura

    CANCER LETTERS   308 ( 2 )   172 - 180   2011年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER IRELAND LTD  

    Inflammation has been demonstrated to play important roles in tumorigenesis, tumor progression, and metastasis. STAT3 has been shown to be frequently activated in a variety of human cancer cells and STAT3 signaling promotes the growth and survival of tumor cells. However, the role of STAT3 of myeloid cells associated with tumors is currently unknown. Suppressor of cytokine signaling-3 (SOCS3) has been shown to be a negative regulator of STAT3. In this study, we used macrophage specific SOCS3 conditional knockout (cKO) mice to investigate the effect of the hyperactivation of STAT3 in macrophages on tumor development and metastasis. In a subcutaneous transplantation model of B16F10 melanoma cells, although tumor sizes were not significantly different, SOCS3-cKO mice survived longer than wild-type (WT) mice did. SOCS3-cKO mice exhibited fewer lung and liver metastatic tumor nodules than WT mice when B16F10 was challenged intravenously. SOCS3(-/-) macrophages stimulated with tumor lysates in vitro exhibited prolonged STAT3 phosphorylation and produced less amount of TNF alpha and IL-6, and higher amount of MCP2/CCL8 than WT macrophages. MCP/CCL8 was induced via STAT3 and exhibited anti-tumor metastatic effect in WT mice. These data suggest that hyperactivation of STAT3 in myeloid cells simultaneously exerted an anti-inflammatory as well as anti-tumor effects. Thus, the targeted inhibition of SOCS3 activity in macrophages may be therapeutic for the suppression of tumor metastasis. (C) 2011 Elsevier Ireland Ltd. All rights reserved.

    DOI: 10.1016/j.canlet.2011.04.024

    Web of Science

    PubMed

    researchmap

  • SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-gamma and IL-17A production 査読

    Reiko Takahashi, Shuhei Nishimoto, Go Muto, Takashi Sekiya, Taiga Tamiya, Akihiro Kimura, Rimpei Morita, Mayako Asakawa, Takatoshi Chinen, Akihiko Yoshimura

    JOURNAL OF EXPERIMENTAL MEDICINE   208 ( 10 )   2055 - 2067   2011年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ROCKEFELLER UNIV PRESS  

    Regulatory T cells (T(reg) cells) maintain immune homeostasis by limiting inflammatory responses. SOCS1 (suppressor of cytokine signaling 1), a negative regulator of cytokine signaling, is necessary for the suppressor functions of T(reg) cells in vivo, yet detailed mechanisms remain to be clarified. We found that Socs1(-/-) T(reg) cells produced high levels of IFN-gamma and rapidly lost Foxp3 when transferred into Rag2(-/-) mice or cultured in vitro, even though the CNS2 (conserved noncoding DNA sequence 2) in the Foxp3 enhancer region was fully demethylated. Socs1(-/-) T(reg) cells showed hyperactivation of STAT1 and STAT3. Because Foxp3 expression was stable and STAT1 activation was at normal levels in Ifn gamma(-/-)Socs1(-/-) T(reg) cells, the restriction of IFN-gamma-STAT1 signaling by SOCS1 is suggested to be necessary for stable Foxp3 expression. However, Ifn gamma(-/-)Socs1(-/-) T(reg) cells had hyper-activated STAT3 and higher IL-17A (IL-17) production compared with Ifn gamma(-/-)Socs1(+/+) T(reg) cells and could not suppress colitis induced by naive T cells in Rag2(-/-) mice. In vitro experiments suggested that cytokines produced by Socs1(-/-) T(reg) cells and Ifn gamma(-/-)Socs1(-/-) T(reg) cells modulated antigen-presenting cells for preferential Th1 and Th17 induction, respectively. We propose that SOCS1 plays important roles in T(reg) cell integrity and function by maintaining Foxp3 expression and by suppressing IFN-gamma and IL-17 production driven by STAT1 and STAT3, respectively.

    DOI: 10.1084/jem.20110428

    Web of Science

    PubMed

    researchmap

  • miR126 positively regulates mast cell proliferation and cytokine production through suppressing Spred1 査読

    Takuma Ishizaki, Taiga Tamiya, Koji Taniguchi, Rimpei Morita, Reiko Kato, Fuyuki Okamoto, Kazuko Saeki, Masatoshi Nomura, Yoshihisa Nojima, Akihiko Yoshimura

    GENES TO CELLS   16 ( 7 )   803 - 814   2011年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL  

    The protein known as Spred1 (Sprouty-related Ena/VASP homology-1 domain-containing protein) has been identified as a negative regulator of growth factor-induced ERK/mitogen-activated protein kinase activation. Spred1 has also been implicated as the target of micro RNA-126 (miR126), a miRNA located within the Egfl7 gene, and is involved in the regulation of vessel development through its role in regulating VEGF signaling. In this study, we examined the role of miR126 and Spred1 in the hematopoietic system, as miR126 has been shown to be overexpressed in leukemic cells. miR126 levels were down-regulated during mast cell differentiation from bone marrow cells, whereas Spred1 expression was inversely up-regulated. Overexpression of miR126 suppressed Spred1 expression and enhanced ERK activity in primary bone marrow cells and MC9 mast cells, which were associated with elevated Fc epsilon RI-mediated cytokine production. To confirm the effect of Spred1 reduction in vivo, we generated hematopoietic cell-specific Spred1-conditional knockout mice. These mice showed increased numbers of mast cells, and Spred1-deficient bone marrow-derived mast cells were highly activated by cross-linking of Fc epsilon R stimulation as well as by IL-3 and SCF stimulation. These results suggest that Spred1 negatively regulates mast cell activation, which is modulated by miR126.

    DOI: 10.1111/j.1365-2443.2011.01529.x

    Web of Science

    PubMed

    researchmap

  • Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-β is mediated by suppression of eomesodermin. 査読

    Ichiyama K, Sekiya T, Inoue N, Tamiya T, Kashiwagi I, Kimura A, Morita R, Muto G, Shichita T, Takahashi R, Yoshimura A

    Immunity   34 ( 5 )   741 - 754   2011年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1016/j.immuni.2011.02.021

    Web of Science

    PubMed

    researchmap

  • The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4(+) T cells 査読

    Takashi Sekiya, Ikkou Kashiwagi, Naoko Inoue, Rimpei Morita, Shohei Hori, Herman Waldmann, Alexander Y. Rudensky, Hiroshi Ichinose, Daniel Metzger, Pierre Chambon, Akihiko Yoshimura

    NATURE COMMUNICATIONS   2   269   2011年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Regulatory T cells (Tregs) have a central role in maintaining immune homoeostasis through various mechanisms. Although the Forkhead transcription factor Foxp3 defines the Treg cell lineage and functions, the molecular mechanisms of Foxp3 induction and maintenance remain elusive. Here we show that Foxp3 is one of the direct targets of Nr4a2. Nr4a2 binds to regulatory regions of Foxp3, where it mediates permissive histone modifications. Ectopic expression of Nr4a2 imparts Treg-like suppressive activity to naive CD4(+) T cells by inducing Foxp3 and by repressing cytokine production, including interferon-gamma and interleukin-2. Deletion of Nr4a2 in T cells attenuates induction of Tregs and causes aberrant induction of Th1, leading to the exacerbation of colitis. Nr4a2-deficeint Tregs are prone to lose Foxp3 expression and have attenuated suppressive ability both in vitro and in vivo. Thus, Nr4a2 has the ability to maintain T-cell homoeostasis by regulating induction, maintenance and suppressor functions of Tregs, and by repression of aberrant Th1 induction.

    DOI: 10.1038/ncomms1272

    Web of Science

    PubMed

    researchmap

  • SOCS1 regulates type I/type II NKT cell balance by regulating IFN gamma signaling 査読

    Masayuki Hashimoto, Kiyokazu Hiwatashi, Kenji Ichiyama, Rimpei Morita, Takashi Sekiya, Akihiro Kimura, Yuki Sugiyama, Toshikatsu Sibata, Kazumichi Kuroda, Reiko Takahashi, Akihiko Yoshimura

    INTERNATIONAL IMMUNOLOGY   23 ( 3 )   165 - 176   2011年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:OXFORD UNIV PRESS  

    Suppressor of cytokine signaling-1 (SOCS1) has been shown to be an essential negative regulator of cytokine responses, including those of IFN gamma, IL-2, IL-4 and IL-7. SOCS1 deficiency resulted in hyperactivation not only of T cells in general but also of NKT cells specifically. Consistent with previous reports, T- and NKT-cell-specific deletion of Socs1 in mice resulted in enhanced sensitivity to ConA-induced hepatitis. Compared with wild-type (WT) NKT cells, SOCS1-deficient NKT cells produced larger quantities of IFN gamma in response to ConA and proliferated faster in response to IL-2 and IL-15. To our surprise, however, SOCS1-deficient NKT cells did not respond to the synthetic glycolipid ligand alpha-galactosylceramide (alpha-GalCer), though they did respond to sulfatide. alpha-GalCer-CD1d-tetramer-positive type I NKT [invariant NKT (iNKT)] cells were marginally detected in the periphery of SOCS1-conditional knockout (cKO) mice, suggesting that most of the SOCS1-deficient NKT cells at the periphery were type II NKT cells. Consistently, invariant V alpha 14 expression was much lower in SOCS1-deficient NKT cells than in WT NKT cells, indicating that iNKT cell homeostasis was abnormal in SOCS1-cKO mice. This reduction in iNKT cells was not observed in mice of an IFN gamma-deficient background. These results suggest that SOCS1 is an important regulator of the balance between type I and type II NKT cells at the periphery.

    DOI: 10.1093/intimm/dxq469

    Web of Science

    PubMed

    researchmap

  • Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance 査読

    Takatoshi Chinen, Kyoko Komai, Go Muto, Rimpei Morita, Naoko Inoue, Hideyuki Yoshida, Takashi Sekiya, Ryoko Yoshida, Kazuhiko Nakamura, Ryoichi Takayanagi, Akihiko Yoshimura

    NATURE COMMUNICATIONS   2   190   2011年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Interleukin 10 (IL-10) and regulatory T cells (Tregs) maintain tolerance to intestinal microorganisms. However, //10(-/-) Rag2(-/-) mice, which lack IL-10 and Tregs, remain healthy, suggesting the existence of other mechanisms of tolerance. Here, we identify suppressor of cytokine signalling 1 (SOCS1) as an essential mediator of immune tolerance in the intestine. Socs1(-/-) Rag2(-/-) mice develop severe colitis, which can be prevented by the reduction of microbiota and the transfer of IL-10-sufficient Tregs. Additionally, we find an essential role for prostaglandin E2 (PGE2) in the maintenance of tolerance within the intestine in the absence of Tregs. Socs1(-/-) dendritic cells are resistant to PGE2-mediated immunosuppression because of dysregulated cytokine signalling. Thus, we propose that SOCS1 and PGE2, potentially interacting together, act as an alternative intestinal tolerance mechanism distinct from IL-10 and Tregs.

    DOI: 10.1038/ncomms1181

    Web of Science

    PubMed

    researchmap

  • Therapeutic effect of IL-12/23 and their signaling pathway blockade on brain ischemia model 査読

    Fumie Konoeda, Takashi Shichita, Hideyuki Yoshida, Yuki Sugiyama, Go Muto, Eiichi Hasegawa, Rinpei Morita, Norihiro Suzuki, Akihiko Yoshimura

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   402 ( 3 )   500 - 506   2010年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Recently, T cell cytokines such as IL-17 and IFN-gamma have been shown to play important roles in the progression of brain injury induced by ischemia We have shown that IL-23 from infiltrated macrophages activates gamma delta T cells, thereby inducing IL-17 from these cells However, deletion of the IL-23 gene in mice showed a more dramatic protective effect against brain ischemia reperfusion (I/R) model than gamma delta T cell depletion did, suggesting that IL-23 plays some other pivotal role in brain injury in addition to its role in IL-17 induction To develop therapeutic methods based on these findings, we examined the effect of the JAK kinase inhibitor CP-690550 and an anti-IL12/23 monoclonal antibody on an I/R model CP-690550 efficiently inhibited IL-17 production from memory T cells in vitro and partly suppressed infarct volume increase after I/R Anti-p40 antibody, which blocks both IL-12 and IL-23, efficiently suppressed I/R injury and improved recovery of neurological deficits The number of IL-17-producing cells was decreased by anti-p40 antibody treatment Thus the JAR inhibitor and anti-p40 antibody, both of which have already been under trial for the treatment of several human inflammatory diseases, appear to be promising therapeutic agents for the amelioration of stroke (C) 2010 Elsevier Inc All rights reserved

    DOI: 10.1016/j.bbrc.2010.10.058

    Web of Science

    PubMed

    researchmap

  • Smad2 and Smad3 Are Redundantly Essential for the TGF-beta-Mediated Regulation of Regulatory T Plasticity and Th1 Development 査読

    Tomohito Takimoto, Yu Wakabayashi, Takashi Sekiya, Naoko Inoue, Rimpei Morita, Kenji Ichiyama, Reiko Takahashi, Mayako Asakawa, Go Muto, Tomoaki Mori, Eiichi Hasegawa, Saika Shizuya, Toshiro Hara, Masatoshi Nomura, Akihiko Yoshimura

    JOURNAL OF IMMUNOLOGY   185 ( 2 )   842 - 855   2010年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER ASSOC IMMUNOLOGISTS  

    Although it has been well established that TGF-beta plays a pivotal role in immune regulation, the roles of its downstream transcription factors, Smad2 and Smad3, have not been fully clarified. Specifically, the function of Smad2 in the immune system has not been investigated because of the embryonic lethality of Smad2-deficient mice. In this study, we generated T cell-specific Smad2 conditional knockout (KO) mice and unexpectedly found that Smad2 and Smad3 were redundantly essential for TGF-beta-mediated induction of Foxp3-expressing regulatory T cells and suppression of IFN-gamma production in CD4(+) T cells. Consistent with these observations, Smad2/Smad3-double KO mice, but not single KO mice, developed fatal inflammatory diseases with higher IFN-gamma production and reduced Foxp3 expression in CD4(+) T cells at the periphery. Although it has been suggested that Foxp3 induction might underlie TGF-beta-mediated immunosuppression, TGF-beta still can suppress Th1 cell development in Foxp3-deficient T cells, suggesting that the Smad2/3 pathway inhibits Th1 cell development with Foxp3-independent mechanisms. We also found that Th17 cell development was reduced in Smad-deficient CD4(+) T cells because of higher production of Th17-inhibotory cytokines from these T cells. However, TGF-beta-mediated induction of ROR gamma t, a master regulator of Th17 cell, was independent of both Smad2 and Smad3, suggesting that TGF-beta regulates Th17 development through Smad2/3-dependent and -independent mechanisms. The Journal of Immunology, 2010, 185: 842-855.

    DOI: 10.4049/jimmunol.0904100

    Web of Science

    PubMed

    researchmap

  • Human plasmacytoid dendritic cells express an atrial natriuretic peptide receptor, guanylyl cyclase-A 査読

    Rimpei Morita, Tomoko Fujita, Takashi Uchiyama, Toshiyuki Hori

    MICROBIOLOGY AND IMMUNOLOGY   53 ( 7 )   403 - 411   2009年7月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-BLACKWELL PUBLISHING, INC  

    Atrial natriuretic peptide is a cardiovascular hormone secreted mainly by the cardiac atria and regulates the volume-pressure homeostasis. The action of ANP is mediated by GC-A. We previously reported that human monocyte-derived dendritic cells express GC-A and respond to ANP with polarization toward a Th2-inducing phenotype. In the present study, we explored the possibility that pDC are subjected to immunoregulation via the ANP/GC-A system. We examined GC-A expression on blood pDC and found that GC-A was not expressed on fresh pDC but was induced after stimulation with CpG-oligodeoxynucleotide AAC-30, IL-3, or interleukin-3 plus CD40 ligand. Activated pDC responded to ANP with an increase in cGMP production, indicating that GC-A expressed on pDC was functional. We investigated whether tonsillar pDC express GC-A by immunohistochemistry and immunofluorescence staining. We found that GC-A(+) HLA-DR(+) cells were present in the T-cell areas and the perivascular areas. Flow cytometric analysis with tonsillar cells confirmed that lineage(-) CD123(high) pDC express GC-A. These results indicate that the ANP/GC-A system is involved in immune regulation through pDC in secondary lymphoid organs.

    DOI: 10.1111/j.1348-0421.2009.00149.x

    Web of Science

    PubMed

    researchmap

  • Harnessing Human Dendritic Cell Subsets to Design Novel Vaccines 査読

    Jacques Banchereau, Eynav Klechevsky, Nathalie Schmitt, Rimpei Morita, Karolina Palucka, Hideki Ueno

    CANCER VACCINES   1174   24 - 32   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BLACKWELL PUBLISHING  

    Dendritic cells (DCs) orchestrate a repertoire of immune responses that endow resistance to infection and tolerance to self. DC plasticity and subsets are prominent determinants of the quality of elicited immune responses. Different DC subsets display different receptors and surface molecules and express different sets of cytokines/chemokines, all of which lead to distinct immunological outcomes. Recent findings on human DC subsets and their functional specialization have provided insights for the design of novel human vaccines.

    DOI: 10.1111/j.1749-6632.2009.04999.x

    Web of Science

    PubMed

    researchmap

  • Dendritic cell subsets in health and disease 査読

    Hideki Ueno, Eynav Klechevsky, Rimpei Morita, Caroline Aspord, Tinghua Cao, Toshimichi Matsui, Tiziana Di Pucchio, John Connolly, Joseph W. Fay, Virginia Pascual, A. Karolina Palucka, Jacques Banchereau

    IMMUNOLOGICAL REVIEWS   219   118 - 142   2007年10月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    The dendritic cell (DC) system of antigen-presenting cells controls immunity and tolerance. DCs initiate and regulate immune responses in a manner that depends on signals they receive from microbes and their cellular environment. They allow the immune system to make qualitatively distinct responses against different microbial infections. DCs are composed of subsets that express different microbial receptors and express different surface molecules and cytokines. Our studies lead us to propose that interstitial (dermal) DCs preferentially activate humoral immunity, whereas Langerhans cells preferentially induce cellular immunity. Alterations of the DC system result in diseases such as autoimmunity, allergy, and cancer. Conversely, DCs can be exploited for vaccination, and novel vaccines that directly target DCs in vivo are being designed.

    DOI: 10.1111/j.1600-065X.2007.00551.x

    Web of Science

    PubMed

    researchmap

  • Delineation of immunoregulatory properties of adult T-cell leukemia cells 査読

    Yasushi Matsubara, Toshiyuki Hori, Rimpei Morita, Shimon Sakaguchi, Takashi Uchiyama

    INTERNATIONAL JOURNAL OF HEMATOLOGY   84 ( 1 )   63 - 69   2006年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CARDEN JENNINGS PUBL CO LTD  

    We characterized leukemic cells from 20 adult T-cell leukemia (ATL) cases and 7 ATL-derived cell lines in terms of Foxp3 messenger RNA (mRNA) expression, cytokine production, cell surface markers associated with regulatory T-cells (Treg), and in vitro inummoregulatory activity and compared the results with those of cells from 3 T-cell-type chronic lymphocytic leukemia (T-CLL) patients and normal CD4(+) T-cells. Real-time polymerase chain reaction analysis showed that cells from 10 ATL cases, 1 T-CLL case, and 1 ATL cell line had higher Foxp3 mRNA levels than CD4(+) T-cells. In 5 ATL cases, Foxp3 levels were comparable to those of CD4(+)CD25(-)T-cells. Flow cytometric analysis revealed that CTLA-4 expression correlated with Foxp3 mRNA level in ATL cells. The cells of all ATL cases examined produced no interleukin 2 or interferon gamma after iono-mycin and phorbolmyristate acetate stimulation. Cases with low Foxp3 expression (Foxp3-low) tended to express higher levels of transforming growth factor beta mRNA, but this trend was not statistically significant. An in vitro inhibition assay showed that the proliferation of normal CD4(+)CD25(-)T-cells stimulated with anti-CD3 monoclonal antibody and autologous dendritic cells was significantly suppressed by coculture with Foxp3-high ATL cells. These results indicate that Foxp3 expression is variable in ATL cases and that Foxp3-high ATL cells, which resemble Treg phenotypically as well as functionally, may be involved in immune suppression in ATL.

    DOI: 10.1532/IJH97.06002

    Web of Science

    PubMed

    researchmap

  • Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells 査読

    Y Matsubara, T Hori, R Morita, S Sakaguchi, T Uchiyama

    LEUKEMIA   19 ( 3 )   482 - 483   2005年3月

     詳細を見る

    記述言語:英語   出版者・発行元:NATURE PUBLISHING GROUP  

    DOI: 10.1038/sj.leu.2403628

    Web of Science

    PubMed

    researchmap

  • Atrial natriuretic peptide polarizes human dendritic cells toward a Th2-promoting phenotype through its receptor guanylyl cyclase-coupled receptor A. 査読

    Morita R, Ukyo N, Furuya M, Uchiyama T, Hori T

    Journal of immunology (Baltimore, Md. : 1950)   170 ( 12 )   5869 - 5875   2003年6月

     詳細を見る

    担当区分:筆頭著者  

    PubMed

    researchmap

  • Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells 査読

    A Yonezawa, R Morita, A Takaori-Kondo, N Kadowaki, T Kitawaki, T Hori, T Uchiyama

    JOURNAL OF VIROLOGY   77 ( 6 )   3777 - 3784   2003年3月

     詳細を見る

    担当区分:筆頭著者   記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Natural alpha interferon (IFN-alpha)-producing cells (IPCs) are now recognized as identical to plasmacytoid dendritic cell (DC) precursors in human blood and are thought to play an important role in antiviral immunity. In the present study, we examined the susceptibility as well as the cellular responses of IPCs to human immunodeficiency virus type 1 (HIV-1) infection. HLA-DR+ CD11c(-) lineage-negative cells (IPCs) were purified from peripheral blood mononuclear cells by magnetic-bead separation and cell sorting. We substantiated that IPCs expressing the major HIV-1 coreceptors, CXCR4 and CCR5, are susceptible to infection of both T-cell-line-tropic NL4-3 and macrophage-tropic JR-CSF HIV-1 by quantification of HIV-1 p24 in the culture supernatants and by provirus integration assay using human conserved Alu-HIV-1 long terminal repeat PCR. To evaluate the cellular response of IPCs to HIV-1, we examined IFN-alpha production and their differentiation into DCs. After incubation with either NL4-3 or JR-CSF, IPCs produced a large amount of IFN-alpha and at the same time underwent morphological differentiation into DCs with upregulation of CD80 and CD86. Heat inactivation of the supernatants containing HIV-1 did not affect the IFN-alpha production and maturation, whereas removal of virions by ultracentrifugation completely nullified both biological effects, indicating that these cellular responses do not require actual HIV-1 infection but are elicited by interaction with HIV-1 virions or certain viral components. In conclusion, these data strongly suggest that IPC can directly recognize and respond to HIV-1 with IFN-alpha production, which is crucial for preventing progress of HIV-1 infection and occurrence of opportunistic infection.

    DOI: 10.1128/JVI.77.6.3777-3784.2003

    Web of Science

    PubMed

    researchmap

  • Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40(+) CD4(+) T cells 査読

    A Kotani, A Takahashi, H Koga, R Morita, H Fukuyama, A Ichinohe, A Ishikawa, T Hori, T Uchiyama

    EUROPEAN JOURNAL OF HAEMATOLOGY   69 ( 5-6 )   318 - 320   2002年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BLACKWELL MUNKSGAARD  

    A patient who developed myasthenia gravis (MG) 25 months after allogeneic bone marrow transplant was immunologically analyzed. OX40(+) CD4(+) T cells in the peripheral blood prominently increased one month before the onset of MG. CD4/CD8 ratios, usually abnormally inverted in patients with chronic graft-vs.-host disease (cGVHD), showed pseudonormalization during the course of MG. We succeeded in uneventful rapid tapering of prednisolone (PSL) using mycophenolate mofetil (MMF). Monitoring of OX40(+) CD4(+) T cells supported the tapering of PSL and MMF as a marker of cGVHD activity. This case suggested the utility of MMF and monitoring of OX40(+) CD4(+) T cells in the management of cGVHD-associated autoimmune diseases.

    DOI: 10.1034/j.1600-0609.2002.02789.x

    Web of Science

    PubMed

    researchmap

  • Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1 査読

    A Yonezawa, T Hori, A Takaori-Kondo, R Morita, T Uchiyama

    JOURNAL OF VIROLOGY   75 ( 9 )   4258 - 4267   2001年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Interaction between the human immunodeficiency virus type I (HIV-1) envelope and the relevant chemokine receptors is crucial for subsequent membrane fusion and viral entry, Although the V3 region of gp120 is known to determine the cell tropism as well as the coreceptor usage, the significance of the binding of the V3 region to the chemokine receptor has not been fully understood, To address this issue, we adopted the pseudotyped virus infection assay in which the V3 region of the T-cell line-tropic (T-tropic) NL4-3 envelope was replaced with a portion of stromal cell derived factor 1 (SDF-1), the ligand of CXCR4. The V3 region of the NL4-3 envelope expression vector was replaced with three different stretches of SDF-1 cDNA, Expression of each chimeric envelope protein was confirmed by immunoprecipitation and Western blotting. Luciferase reporter viruses were prepared by cotransfection of the pNL4-3.Luc.E-R- vector and each chimeric envelope expression vector, and the infection assay was then carried out, We showed that pseudotyped viruses with one of the chimeric envelopes, NL4-3/SDF1-51, could infect U87.CD4.CXCR4 but not U87.CD4 or U87.CXCR4 cells and that this infection was inhibited by the ligand of CXCR4, SDF-1 beta by anti-human SDF-1 antibody, or by an anti-CD4 antibody, Leu3a, in a dose-dependent manner, Furthermore, chimeric NL-4-3/SDF1-51 gp120 significantly inhibited binding of labeled SDF-1 to CXCR4. It was suggested that replacement of the V3 region of the NL4-3 envelope with SDF-1 preserved the CD4-dependent infectivity of T-tropic HIV-1, These results indicate that binding between the V3 region and the relevant coreceptor is important for viral entry, whether its amino acid sequence is indigenous to the virus or not.

    DOI: 10.1128/JVI.75.9.4258-4267.2001

    Web of Science

    PubMed

    researchmap

  • Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappa B activation induced by OX40 signaling 査読

    A Takaori-Kondo, T Hori, K Fukunaga, R Morita, S Kawamata, T Uchiyama

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   272 ( 3 )   856 - 863   2000年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC  

    OX40 is a member of the tumor necrosis factor receptor (TNF-R) superfamily. We observed that overexpression of OX40 activated NF-kappa B, which was inhibited by dominant negative forms of TRAF2, NF-kappa B-inducing kinase (NIK), and IkappaB kinase (IKR) alpha. This indicates that OX40 signaling leads to NF-kappa B activation through the same cascade as TNF-R2. We then investigated the negative regulatory function of TRAF3 on OX40-induced NF-kappa B activation. TRAF3 blocked OX40-, TRAF2-induced NP-kappa B activation, but not NIK- and IKK alpha-induced NF-kappa B activation, indicating that TRAF3 blocks the pathway between TRAF2 and NIK. C-terminal deletion mutants as well as the N-terminal deletion mutant of TRAF3 inhibited NP-kappa B activation induced by OX40 or TRAF2. Since TRAF3 bound to OX40 through the C-terminal TRAF domain, the C-terminal domain is likely to work as a dominant negative mutant to compete the recruitment of TRAF2 to the receptor, which transmits the signal from OX40 to the downstream, NIK kinase. On the other hand, the N-terminal domain of TRAF3 seems to affect the downstream of TRAF2 binding. Thus, it is suggested that TRAF3 actively inhibits NF-kappa B activation induced by OX40. (C) 2000 Academic Press.

    DOI: 10.1006/bbrc.2000.2860

    Web of Science

    PubMed

    researchmap

▼全件表示

書籍等出版物

  • 細胞工学別冊 ダイレクトリプログラミング

    森田林平, 笠原秀範, 吉村昭彦( 担当: 分担執筆 範囲: 線維芽細胞→血管内皮細胞:初代成人皮膚線維芽細胞からのETVECの作製方法)

    秀潤社  2015年4月 

     詳細を見る

  • 臨床粘膜免疫学

    吉村昭彦, 高田伊知郎, 森田林平( 担当: 分担執筆 範囲: 生理的ならびに病態形成局面におけるTh17とiTreg細胞の役割)

    シナジー  2011年1月 

     詳細を見る

MISC

  • アルミニウム含有食品添加物で誘導されるアレルギーと腸管上皮細胞死の解析

    若林 あや子, 大脇 敦子, 岩槻 健, 田中 啓介, 長田 康孝, 西山 康裕, 松根 彰志, 森田 林平

    日本栄養・食糧学会大会講演要旨集   75回   124 - 124   2021年7月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本栄養・食糧学会  

    researchmap

  • Serum Soluble CD86, Still a Prognostic Factor in the Novel Agent Era in Multiple Myeloma Patients, Is Produced By Myeloma Cells with High CD86 Variant 3 Expression

    Mariko Ishibashi, Ryosuke Kinoshita, Koiti Inokuchi, Hiroshi Handa, Makoto Sasaki, Norio Komatsu, Yoichi Imai, Norina Hiroike, Junji Tanaka, Sakae Tanosaki, Shigeki Ito, Mika Sunakawa, Toshio Asayama, Yasuko Kuribayashi-hamada, Rimpei Morita, Hideto Tamura

    BLOOD   134   2019年11月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:AMER SOC HEMATOLOGY  

    0

    DOI: 10.1182/blood-2019-124635

    Web of Science

    researchmap

  • 免疫疾患と妊娠 免疫学的知見による新しい流早産発症メカニズムの解明

    根岸 靖幸, 加藤 雅彦, 島 義雄, 市川 智子, 竹下 俊行, 森田 林平, 高橋 秀実

    日本臨床免疫学会総会プログラム・抄録集   47回   78 - 78   2019年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本臨床免疫学会  

    researchmap

  • Notch-mediated conversion of activated T cells into stem cell memory T cells facilitates adoptive cancer immunotherapy

    Taisuke Kondo, Rimpei Morita, Akihiko Yoshimura

    CYTOKINE   100   59 - 59   2017年12月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD  

    Web of Science

    researchmap

  • CLINICAL AND IMMUNOLOGICAL SIGNIFICANCE OF RADIOGRAPHIC THYMIC ALTERATIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS

    O. Murata, K. Suzuki, H. Sugiura, Y. Kondo, M. Takeshita, H. Yasuoka, K. Yamaoka, K. Koga, R. Morita, A. Yoshimura, T. Takeuchi

    ANNALS OF THE RHEUMATIC DISEASES   76   1021 - 1022   2017年6月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:BMJ PUBLISHING GROUP  

    DOI: 10.1136/annrheumdis-2017-eular.3933

    Web of Science

    researchmap

  • ETV2による血管内皮細胞へのリプログラム分子機序の解明

    森田 林平

    先進医薬研究振興財団研究成果報告集   2016年度   130 - 131   2017年3月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公財)先進医薬研究振興財団  

    researchmap

  • Reprogramming of T cells from effector to stem cell memory by Notch signaling

    T. Kondo, R. Morita, Y. Kassai, T. Sekiya, S. Chikuma, Y. Gotou, M. Kanamori, T. Miyazaki, M. Kubo, A. Yoshimura

    EUROPEAN JOURNAL OF IMMUNOLOGY   46   986 - 986   2016年8月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • BRUTON'S TYROSINE KINASE (BTK) IS AN ESSENTIAL COMPONENT FOR NLRP3 INFLAMMASOME ACTIVATION AND A POTENTIAL THERAPEUTIC TARGET FOR INFLAMMATION AFTER ISCHEMIC BRAIN INJURY

    M. Ito, T. Shichita, A. Yoshimura, R. Morita

    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM   36   459 - 459   2016年6月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:SAGE PUBLICATIONS INC  

    Web of Science

    researchmap

  • ENHANCED IGG4 PRODUCTION BY FOLLICULAR HELPER TYPE 2 T CELLS IN IGG4-RELATED DISEASE

    M. Akiyama, H. Yasuoka, K. Yamaoka, K. Suzuki, Y. Kaneko, H. Kondo, Y. Kassai, K. Koga, T. Miyazaki, R. Morita, A. Yoshimura, T. Takeuchi

    ANNALS OF THE RHEUMATIC DISEASES   75   180 - 180   2016年6月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:BMJ PUBLISHING GROUP  

    DOI: 10.1136/annrheumdis-2016-eular.2444

    Web of Science

    researchmap

  • 神経・免疫のクロストーク 脳虚血と炎症

    伊藤美菜子, 七田崇, 七田崇, 森田林平, 吉村昭彦

    最新医学   71 ( 2 )   243‐249 - 242   2016年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:最新医学社  

    CiNii Books

    J-GLOBAL

    researchmap

  • Identification of Serum Biomarker for the Glandular Dysfunction of Primary Sjogren's Syndrome

    Ayumi Nishikawa, Katsuya Suzuki, Yoshiaki Kassai, Yuumi Gotou, Takahiro Miyazaki, Maiko Takiguchi, Rimpei Morita, Akihiko Yoshimura, Tsutomu Takeuchi

    ARTHRITIS & RHEUMATOLOGY   67   2015年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • 臨床応用を目指した基礎研究 多能性幹細胞とreprogramming技術 成人皮膚線維芽細胞から血管内皮細胞への直接誘導

    森田林平, 笠原秀範, 吉村昭彦

    日本臨床   73   155 - 159   2015年6月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • INCREASED T FOLLICULAR HELPER SUBSET 2 RELATED TO INCREASED IGG4 AND PLASMABLASTS THROUGH IL-4 IN IGG4-RELATED DISEASE

    M. Akiyama, K. Suzuki, H. Yasuoka, K. Yamaoka, M. Takeshita, Y. Kaneko, H. Kondo, Y. Kassai, T. Miyazaki, R. Morita, A. Yoshimura, T. Takeuchi

    ANNALS OF THE RHEUMATIC DISEASES   74   112 - 112   2015年6月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:BMJ PUBLISHING GROUP  

    DOI: 10.1136/annrheumdis-2015-eular.4673

    Web of Science

    researchmap

  • Proportion of Peripheral Plasmacytoid Dendritic Cells and Plasmablasts Reflects Disease Activity in IgG4-related Disease.

    Mitsuhiro Akiyama, Katsuya Suzuki, Yoshiaki Kassai, Takahiro Miyazaki, Rimpei Morita, Akihiko Yoshimura, Tsutomu Takeuchi

    ARTHRITIS & RHEUMATOLOGY   66   S542 - S543   2014年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • Dysregulated Serum Interleukin 16 Concentration Associated with Clinical Disease Activity in Patients with Rheumatoid Arthritis Is Efficiently Corrected By Immunological Intervention

    Atsuko Murota, Katsuya Suzuki, Yoshiaki Kassai, Takahiro Miyazaki, Rimpei Morita, Akihiko Yoshimura, Tsutomu Takeuchi

    ARTHRITIS & RHEUMATOLOGY   66   S459 - S460   2014年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • Integrated Comprehensive Analysis of Immune Cell Subsets and Serum Protein Profile Identifies the Role of Pre-Germinal Center B Cells in Sjogren's Syndrome Pathogenesis

    Yoshiaki Kassai, Katsuya Suzuki, Rimpei Morita, Maiko Takiguchi, Rina Kurisu, Takahiro Miyazaki, Akihiko Yoshimura, Tsutomu Takeuchi

    ARTHRITIS & RHEUMATOLOGY   66   S439 - S439   2014年10月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • 濾胞ヘルパーT細胞の分化誘導

    森田林平

    月刊臨床免疫・アレルギー科   56 ( 6 )   694 - 699   2011年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:科学評論社  

    CiNii Books

    J-GLOBAL

    researchmap

  • miR126 positively regulates mast cell proliferation and cytokine production through suppressing Spred1 (vol 16, pg 803, 2011)

    Takuma Ishizaki, Taiga Tamiya, Koji Taniguchi, Rimpei Morita, Reiko Kato, Fuyuki Okamoto, Kazuko Saeki, Masatoshi Nomura, Yoshihisa Nojima, Akihiko Yoshimura

    GENES TO CELLS   16 ( 9 )   984 - 984   2011年9月

     詳細を見る

    記述言語:英語   出版者・発行元:WILEY-BLACKWELL  

    DOI: 10.1111/j.1365-2443.2011.01543.x

    Web of Science

    researchmap

  • Human T follicular helper cells comprise subsets specialized for help of distinct B cell subsets

    Salah-Eddine Bentebibel, Nathalie Schmitt, Rimpei Morita, Jacques Banchereau, Hideki Ueno

    JOURNAL OF IMMUNOLOGY   184   2010年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:AMER ASSOC IMMUNOLOGISTS  

    Web of Science

    researchmap

  • Human T Follicular Helper Cells Comprise Subsets Specialized for Help of Distinct B Cell Subsets

    Salah-Eddine Bentebibel, Nathalie Schmitl, Rimpei Morita, Jacques Banchereau, Hideki Ueno

    CLINICAL IMMUNOLOGY   135   S16 - S16   2010年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    DOI: 10.1016/j.clim.2010.03.052

    Web of Science

    researchmap

  • 【サイトカインの新時代 炎症と抗炎症のバランス制御から治療戦略まで】 Cell Tech Eye Inflammasome

    森田 林平, Flavell Richard

    細胞工学   28 ( 11 )   1116 - 1117   2009年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:(株)学研メディカル秀潤社  

    researchmap

  • Understanding Human Myeloid Dendritic Cell Subsets for the Rational Design of Novel Vaccines

    Eynav Klechevsky, Anne-Laure Flamar, Maochang Liu, Rimpei Morita, Luann Thompson-Snipes, Karolina Palucka, Hideki Ueno, Gerard Zurawski, Jacques Banchereau

    CLINICAL IMMUNOLOGY   131   S132 - S132   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    DOI: 10.1016/j.clim.2009.03.527

    Web of Science

    researchmap

  • ICOS(low)CXCR5(intermediate) T Follicular Helper Cell Subset Secretes the Largest Amounts of IL-21 upon Interaction with Naive B cells

    Salah Eddine Bentebibel, Nathalie Schmitt, Rimpei Morita, Jacques Banchereau, Hideki Ueno

    CLINICAL IMMUNOLOGY   131   S169 - S169   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    DOI: 10.1016/j.clim.2009.03.501

    Web of Science

    researchmap

  • Human CXCR5+CD4+B Helper T Cells Consists of Subsets Which Differentially Regulate Naive B Cell Differentiation

    Rimpei Morita, Nathalie Schmitt, Salah Eddine Bentebibel, Sandra Zurawski, Jacques Banchereau, Hideki Ueno

    CLINICAL IMMUNOLOGY   131   S20 - S20   2009年

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    DOI: 10.1016/j.clim.2009.03.053

    Web of Science

    researchmap

  • Interstitial dendritic cells and Langerhans cells differentially prime immoral and cellular immunity

    Eynav Klechevsky, Hideki Ueno, Rimpei Morita, Yorani Reiter, Francine Briere, Karolina A. Palucka, Jacques Banchereau

    JOURNAL OF IMMUNOLOGY   176   S59 - S59   2006年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:AMER ASSOC IMMUNOLOGISTS  

    Web of Science

    researchmap

  • Natural interferon producing cells(IPC)とHIV-1の相互作用の解析

    森田 林平, 堀 利行, 米澤 明仁, 高折 晃史, 門脇 則光, 北脇 年雄, 内山 卓

    日本エイズ学会誌   4 ( 4 )   313 - 313   2002年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本エイズ学会  

    researchmap

  • 末梢血pDC2(I型インターフェロン産生細胞)のHIV-1感染感受性とインターフェロン産生応答

    米澤 昭仁, 堀 利行, 高折 晃史, 門脇 則光, 北脇 年雄, 森田 林平, 内山 卓

    日本免疫学会総会・学術集会記録   31   112 - 112   2001年12月

     詳細を見る

    記述言語:日本語   出版者・発行元:(NPO)日本免疫学会  

    researchmap

  • 末梢血樹状細胞サブセットにおけるHIV-1感染と免疫応答の相異

    米澤 昭仁, 堀 利行, 高折 晃史, 門脇 則光, 北脇 年雄, 森田 林平, 内山 卓

    日本エイズ学会誌   3 ( 4 )   373 - 373   2001年11月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本エイズ学会  

    researchmap

  • 悪性リンパ腫と遺伝子解析

    安田典正, 森田林平, 大森聖一, 臼井忠男

    京都市立病院紀要   17 ( 1 )   3 - 10   1997年12月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

▼全件表示

講演・口頭発表等

  • Serum Soluble CD86, Still a Prognostic Factor in the Novel Agent Era in Multiple Myeloma Patients, Is Produced By Myeloma Cells with High CD86 Variant 3 Expression

    Mariko Ishibashi, Ryosuke Kinoshita, Koiti Inokuchi, Hiroshi Handa, Makoto Sasaki, Norio Komatsu, Yoichi Imai, Norina Hiroike, Junji Tanaka, Sakae Tanosaki, Shigeki Ito, Mika Sunakawa, Toshio Asayama, Yasuko Kuribayashi-hamada, Rimpei Morita, Hideto Tamura

    BLOOD  2019年11月  AMER SOC HEMATOLOGY

     詳細を見る

    開催年月日: 2019年11月

    記述言語:英語  

    0

    researchmap

  • 免疫疾患と妊娠 免疫学的知見による新しい流早産発症メカニズムの解明

    根岸 靖幸, 加藤 雅彦, 島 義雄, 市川 智子, 竹下 俊行, 森田 林平, 高橋 秀実

    日本臨床免疫学会総会プログラム・抄録集  2019年10月  日本臨床免疫学会

     詳細を見る

    開催年月日: 2019年10月

    記述言語:日本語  

    researchmap

産業財産権

受賞

  • 奨励賞

    2015年6月   第7回シグナルネットワーク研究会  

    森田 林平

     詳細を見る

  • 優秀演題賞

    2013年7月   第34回日本炎症・再生医学会学術集会  

    森田 林平

     詳細を見る

  • 助成金

    2007年1月   キ-ストンシンポジウム  

    森田 林平

     詳細を見る

  • 海外留学助成金

    2004年11月   先進医薬研究振興財団  

    森田 林平

     詳細を見る

共同研究・競争的資金等の研究課題

  • エンドサイトーシスによるNLRP3インフラマソーム形成制御機構と生理的意義の解明

    研究課題/領域番号:22K07140  2022年4月 - 2025年3月

    日本学術振興会  日本学術振興会 基盤研究(C)  基盤研究(C)

    森田 林平

      詳細を見る

    担当区分:研究代表者 

    配分額:4160000円 ( 直接経費:3200000円 、 間接経費:960000円 )

    researchmap

  • 開放骨折への即時骨接合+局所抗生剤高濃度持続投与法の感染率低下、遊離骨片温存作用

    研究課題/領域番号:22K09196  2022年4月 - 2025年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    佐藤 陽介, 森田 林平, 原 義明, 平林 篤志, 横堀 将司, 秋元 敏雄

      詳細を見る

    配分額:4160000円 ( 直接経費:3200000円 、 間接経費:960000円 )

    researchmap

  • マクロファージ死を利用した新規腫瘍免疫療法の開発

    2018年12月

    テルモ生命科学芸術財団  研究開発助成 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:2000000円 ( 直接経費:2000000円 )

    researchmap

  • マクロファージ死の新規制御分子の同定と腫瘍免疫療法の開発

    2018年10月

    武田科学振興財団  生命科学研究助成 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:10000000円

    researchmap

  • Gelsolinによるマクロファージ死抑制機序の解明と腫瘍免疫療法への応用

    2018年 - 2019年

    第一三共生命科学研究振興財団  研究助成金 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:2000000円 ( 直接経費:2000000円 )

    researchmap

  • 炎症環境におけるプログラム細胞死クロストークの解明

    2017年12月

    上原記念生命科学財団  研究助成金 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:5000000円

    researchmap

  • クラスリンによるNLRP3インフラマソーム形成制御の分子メカニズムと生理的意義の解明

    2017年11月

    内藤記念科学振興財団  研究助成 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:3000000円

    researchmap

  • NLRP3を介したgelsolinによるプログラム細胞死の制御機序の解明

    2017年 - 2018年

    国際医療福祉大学学内研究費  一般研究 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:1400000円

    researchmap

  • インフラマソーム形成におけるNLRP3リン酸化修飾の生理的意義の解明

    2016年4月 - 2019年3月

    日本学術振興会  基盤研究(B) 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:17420000円 ( 直接経費:13400000円 、 間接経費:4020000円 )

    researchmap

  • ETV2による血管内皮細胞へのリプログラム分子機序の解明

    2015年

    先進医薬研究振興財団  血液医学分野 一般研究助成 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:1000000円

    researchmap

  • ETV2を中心とした細胞直接リプログラミングによる血液細胞の作成

    2014年4月 - 2016年3月

    日本学術振興会  挑戦的萌芽研究 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:3640000円 ( 直接経費:2800000円 、 間接経費:840000円 )

    researchmap

  • 直接リプログラミングによるヒト線維芽細胞からリンパ球の作製方法の確立

    2014年 - 2015年

    慶應義塾大学学事振興資金  研究補助 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:1000000円

    researchmap

  • 直接リプログラミングによるヒト造血幹細胞の作製

    2014年

    武田科学振興財団  ビジョナリーリサーチ助成 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:2000000円

    researchmap

  • TLRシグナルはBtkを介してNLRP3インフラマゾームの活性化を制御するのか?

    2012年4月 - 2014年3月

    日本学術振興会  新学術領域研究(研究領域提案型) 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:9620000円 ( 直接経費:7400000円 、 間接経費:2220000円 )

    researchmap

  • SOCS1によるヘルパーT細胞分化制御機構の解明

    2012年

    武田科学振興財団  医学系研究奨励継続 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:3000000円

    researchmap

  • 濾胞性ヘルパーT細胞の分化制御におけるSOCS1の機能の解明

    2011年

    持田記念医学薬学振興財団  研究助成 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:3000000円

    researchmap

  • SOCS1による濾胞性ヘルパーT細胞分化制御機構の解明

    2011年

    先進医薬研究振興財団  血液医学分野 一般研究助成 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:1000000円

    researchmap

  • ヒト末梢血CD4T細胞から造血幹細胞へのリプログラミング方法の開発

    2011年

    慶應義塾学事振興資金  個人研究B 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:200000円

    researchmap

  • SOCS1による濾胞性ヘルパーT細胞の分化及び機能制御の解明

    2010年4月 - 2013年3月

    日本学術振興会  基盤研究(C) 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:4550000円 ( 直接経費:3500000円 、 間接経費:1050000円 )

    researchmap

  • SOCS1によるヘルパーT細胞分化制御機構の解明

    2010年

    武田科学振興財団  医学系研究奨励 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:3000000円

    researchmap

  • 心房性ナトリウム利尿ペプチドによる樹状細房を中心とした免疫調整作用の解析

    2004年4月 - 2006年3月

    日本学術振興会  若手研究(B) 

    森田 林平

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:3000000円 ( 直接経費:3000000円 )

    researchmap

▼全件表示